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ABSTRACT
HOST RESPONSES TO THE PHENOLIC-GLYCOLIPID-1 ANTIGEN OF
MYCOBACTERIUM LEPRAE
by
Richard W. Truman
Antibody responses to the apparently species specific 
phenolic-glycolipid-1 (Phen-Gl-1) antigen of Mycobacterium 
leprae were examined in humans and armadillos using enzyme- 
linked immunosorbent assays (ELISA). Statistical 
definitions for the interpretation of positive and negative 
reactions were derived, a retrospective serological survey 
of armadillos indicated that leprosy in the wild armadillo 
is a naturally acquired zoonosis. Presently 12.5% of the 
armadillos in 2 parishes in south central Louisiana have 
detectable IgM antibodies to Phen-Gl-1. Approximately 2.7% 
of these histologically exhibit clinical disease.
Antibodies were not detected in Florida armadillo sera. 
Variations in prevalence rates were noted, and may be due 
to environmental conditions, population characteristics or 
some intricacies in the transmission of leprosy. Naturally 
acquired leprosy in the armadillo may be used as a model to 
study transmission and baseline data have been derived.
The ELISA was shown to have application in the management 
of experimental leprosy infections in armadillos.
Resistant armadillos were noted to have an irregular or
absent antibody response to the Phen-Gl-1 antigen over the 
course of an experimental infection. Armadillos infected 
in the wild also had an irregular IgM response.
Susceptible armadillos appeared to have a long-term IgM 
antibody response to Phen-Gl-1 becoming detectable some 186 
days post-experimental infection. This antibody remained 
detectable for up to 1140 days post-infection. Antibody 
responses of susceptible armadillos correlated with the 
harvestable load of M. leprae in liver tissues and ELISA 
absorbances successfully predicted a harvest result 97% of 
the time. IgM antibodies to Phen-Gl-1 were earlier and 
more reliable than other indicators of infection previously 
applied. IgM, IgA, and IgG antibodies to Phen-Gl-1 were 
detected in leprosy patients and contacts. IgM appeared to 
be the predominate isotype detectable. Human patients 
showed no significant correlation of antibody relative 
their clinical status. IgM antibodies to Phen-Gl-1 were 
depressed as a result of therapy with thalidomide. 
Monitoring Phen-Gl-1 antibodies in human patients is not 
predictive of patient status or reaction and does not seem 
indicated for clinical management.
x
CHAPTER 1; INTRODUCTION
Leprosy is a disease of certain antiquity yet infects 
approximately 11 million people in the world today (173)^  
Caused by Mycobacterium leprae, the disease progresses 
slowly in man and can result in severe deformation, 
debilitation, and death. Patients present a complex 
spectrum of clinical and immunologic symptoms (27,85)#
They are plagued by a number of acute reactional states and 
management of the leprosy patient is complex. Early 
diagnosis of leprosy is helpful in avoiding pain and 
suffering, and techniques to aid diagnosis and management 
are greatly needed (58) p
Serology holds hope for use in the early diagnosis of 
leprosy and may prove useful in the management of leprosy 
patients. However, the serology of M. leprae has been most 
complicated. Previous serologic techniques used undefined 
antigen mixtures and lacked both sensitivity and 
specificity (130)_ Recently a phenolic glycolipid antigen 
of M. leprae was isolated. The phenolic-glycolipid-1 
(Phen-Gl-1) antigen is chemically defined and apparently 
species specific for M. leprae (22,33,78)# 
specificity of this antigen may alleviate many problems 
previously encountered in leprosy serology.
The purpose of these investigations was to provide 
basic information about the antibody response to the 
phenolic-glycolipid-1 antigen and to develop it further for
2use in leprosy. The following chapters describe the 
development, evaluation and application of enzyme-linked 
immunosorbent assays (ELISA) for use in armadillos and 
humans. The applications include epidemiology and 
prospective management.
CHAPTER 2; REVIEW OF LITERATURE
Leprosy (Hansen's disease (HD); hanseniasis) is a 
chronic mycobacterial disease primarily affecting the 
peripheral nervous system and secondarily involving skin 
and other tissues. Generally a disease of the Third World, 
training in leprosy is usually neglected in developed 
countries (58) _ fj0 the reader's understanding, a brief
review has been prepared. Characteristics of the M. leprae 
organism, transmission, classification, epidemiology and 
immunology of leprosy are discussed in general. Emphasis 
has been given to serologic events in leprosy and the assay 
systems used to detect them.
The organism;
Mycobacterium leprae was first described by 
Armauer Hansen in 1873 (59) ^ iphe organism is an acid fast 
bacillus of apparently high infectivity but low 
pathogenicity (84) ^ Although there are occasional reports 
to the contrary, a general consensus holds that M. leprae 
has not been cultivated on artificial media and researchers 
must rely on iri vivo propagation methods as a source of M. 
leprae. The mouse footpad, the nine banded armadillo 
(Dasypus novemcinctus), the mangabey monkey and a variety 
of immunodeficient animals have been shown to support 
growth of M. leprae. Shepard first reported growth of M. 
leprae (from nasal washings) in the mouse footpad in 1960
4(178). The mouse supports limited replication and the 
infection does not disseminate. This model is currently- 
used for drug sensitivity evaluations, and evaluation of 
experimental vaccines. Growth of M. leprae in the 
armadillo was first reported by Kirchheimer and Storrs in 
1971 (97). The armadillo uniquely sustains a disseminated 
infection and is in common use for the production of large 
quantities of M. leprae. Infection in the mangabey monkey 
has only recently been reported and, along with the 
armadillo, may develop as another animal model to study the 
host-parasite relationship in leprosy (117).
Identification of M. leprae is presumptively made on the 
basis of an acid fast bacillus whose acid fastness is 
pyridine extractable (115) and has the ability to oxidize 
DOPA (144,145). More specific methods for identification, 
including antigenic analysis and DNA hybridization, are 
developing (8>, Confirmation is usually dependent on a 
histological examination which requires presentation of a 
typical leprosy profile with acid-fast bacilli in 
peripheral nerves (86). m . leprae has no flagella or 
observable appendages, and appears to be nonmotile (143).
Antigenically, M. leprae are similar to organisms of 
the MAIS complex (M. avium, M. intracellulare, M. 
scrofulaceum) (12). They bear a number of antigens which 
cross react with these and other mycobacterial species. 
Using sera from lepromatous patients or antisera raised in 
rabbits, serological cross reactions have been noted with
5M. avium, M. gallinarum, M. simiae, M. chitae, (103) m . 
smegmatis, M. kansasii, M. phlei, M. fortuitum, M. balnei 
(133) an(j m . bovis (BCG) (63) ^ using lymphocyte blast 
transformation in humans, mice and rabbits sensitized with 
leprae; M. bovis (BCG), M. duvallii (54) giluum, M. 
nonchromoqenicum and M. vaccae (189) were shown to cross 
react with M. leprae.
Skin test cross reactivities and monoclonal antibodies 
have added M. gordonae to the list (50,81)_ while the 
antigenic determinants responsible for cross reactions may 
not be major antigenic complexes of M. leprae, even minor 
complexes in mycobacteria can promote strong cross 
reactions. This phenomenon has been coined "Original 
Mycobacterial Sin" (4). The cross reactivity of M. leprae 
with other mycobacterial species has complicated 
vaccination trials and attempts to monitor M. leprae- 
specific immune responses (H).
A number of investigators have sought to identify 
antigenic determinants that are specific for M. leprae.
The first refinement of M. leprae antigen systems was the 
so-called antigen 7 by Harboe (65,135)# This mixture of 
antigens was identified by gel diffusion studies with 
lepromatous sera on sonicated fractions of whole M. leprae. 
The majority of lepromatous patients examined had 
antibodies that precipitated this antigen. While 
recognized as a mixture of determinants, some sought to 
enhance the specificity of this antigen by absorbing test
6sera with a variety of other mycobacterial species (e.g., 
BCG, M. avium, and M. nonchromogenicum) (61,67)#
Absorption to promote specificity did not meet the criteria 
for a species-specific antigen (61). Recently, Ivanyi and 
Gillis ( r i n d e p e n d e n t l y  reported a monoclonal antibody 
that reacts with a specific antigenic determinant on M. 
leprae. The epitope with which this antibody reacts is 
believed to be protein, but the determinant has not been 
defined (81,50).
Brennan (Colorado State University) has identified a 
specific antigen in the lipid fraction of M. leprae. A 
phenolic glycolipid in nature, its specificity is imparted 
in a trisaccharide terminus of: 3-0-Me-rhamnose;
2,3-d-O-Me-rhamnose and 3,6-d-O-Me-glucose glycosidically 
linked to the phenol substituent (21,77) ^ qihe 
immunodominant portion of the molecule appears to be the 
terminal glucose residue (25) ^ rphe xipid structure is 
related to mycoside-A of M. kansasii and is similar to 
other oligosaccharides found on mycobacteria of the MAIS 
complex (78)# Serological cross reactivities have not been 
reported with other mycobacterial species. As yet, little 
is known of the immune response to this antigen.
Epidemiology:
The rate at which leprosy spreads depends on the 
proportion of susceptible persons in the population and 
their opportunity for contact with M. leprae. Adults are
7thought to be relatively insusceptible; most attempts to 
infect volunteers have failed and conjugal leprosy is only 
about 5%. Children seem most susceptible. When there is 
leprosy in a family, up to 100% of the children may develop 
the disease (68) < ^he incubation period for leprosy is 
thought to be 3 to 5 years. Shorter and longer periods of 
incubation have been reported. Although the bacilli do not 
cross the placenta, bacillary antigens do. The effect of 
these antigens on eventual susceptibility is uncertain. 
Leprosy has world distribution, but is highest in tropical 
and sub-tropical climates. It is found less commonly in 
the Mediterranean population, Australian aborigines, and 
natives of Texas and Louisiana (58).
Transmission;
Transmission of leprosy may be direct or indirect, but 
direct contact may be more effective. Long-term close 
contact seems to be required for the establishment of 
infection. The exact site and mode of entry of M. leprae 
into the host has not been established. The organism 
probably enters the body as any other pathogen, either 
through the skin, the respiratory tract, or the 
gastrointestinal tract. Broken epithelium may be necessary 
for entry through the skin. Large numbers of organisms are 
shed in the nasal secretions of a leprosy patient with high 
bacillary load, which may imply a respiratory mode of 
transmission (84) ^ outcome of infection may be
8determined by the organism's route of entry, the size of 
the inoculum and the resulting host-parasite interaction. 
The route of entry could determine how the organism is 
presented to the immune system (193)p The inoculum size to 
which the potential host is exposed (either a single event 
or chronically over time) could also influence the response 
of the host immune system.
Environmental factors influencing transmission of 
leprosy have been described. High relative humidity and 
warm temperatures correlate with increased prevalence rates 
of leprosy (80)# Kazda recently isolated a M. leprae-like 
organism from a sphagnum bog in Norway. The organism is 
DOPA and pyridine positive, and reportedly bears the 
phenolic glycolipid-1 antigen (92,25)# The role of the 
environment or environmental microorganisms as pathogens 
or additional factors influencing the transmission of 
leprosy has not been described. Stanford speculated that 
environmental mycobacteria antigenically similar to 
M. leprae may contribute to susceptibility for leprosy 
(190). Antibodies elicted from previous exposure to 
environmental mycobacteria may mask epitopes important in 
the cell-mediated recognition of M. leprae (H^.
The clinical form of disease presented by a given 
individual may be dependent upon the route of entry or host 
factors such as genetic makeup, nutrition and active 
infections or therapy which may play a part in reduced host 
resistance (84) _ jn recent years, there has been evidence
9that the immunological status of the host may be the most
important factor. The clinical spectrum seen in leprosy is
closely related to the status of the cell-mediated immunity
(CMI) of the host. M. leprae are not eliminated from the
body by humoral immunity (antibody) but are controlled or 
eliminated by the CMI (200).
Classification:
Disease classification schemes in leprosy must take 
into account the clinical spectrum of the disease, the 
bacterial load, the histopathological appearance of the 
lesions and/or the immunological status of the patient
. one the most widely used classification systems is 
the five-group Ridley-Jopling classification scheme (153). 
This system classifies leprosy patients based on 
histopathologic features and the response to a lepromin 
test.
The lepromin test consists of intradermal injection of 
a phenol-treated suspension of heat-killed organisms 
harvested from tissue of a high bacillary load (102).
Three types of responses have been described (149).
Medina reaction, which peaks at 4 to 6 hours, measures 
antibody; the Fernandez reaction detects the presence of 
competent T lymphocytes with a positive reaction at 48 to 
72 hours as a delayed-type hypersensitivity reaction; 
the Mitsuda (or lepromin) reaction is noted grossly or 
histologically at the injection site 2 to 3 weeks post­
10
inoculation. A positive Mitsuda (well-defined tuberculoid 
granuloma) indicates that a person has the capacity to 
develop competent cell mediated immunity for M. leprae.
Across the Ridley-Jopling scale there are five 
classifications of leprosy, ranging from polar tuberculoid 
(TT) to polar lepromatous leprosy (LL). Tuberculoid 
leprosy is associated with a positive Fernandez (lepromin) 
reaction. Patients of this class have competent CMI but 
little circulating antibody is found (30). Clinically, 
there are few discrete asymmetrical lesions, typically 
large and erythematous or hypopigmented with a dry 
sometimes scaly surface. The outer border is sharply 
defined and elevated. The inner border is vague and slopes 
down to a flat, atropic center which exhibits anhidrosis 
anesthesia, and a lack of hair growth. Peripheral nerves 
in the region of the lesion may be thickened and palpable. 
Early manifestations of this form of leprosy may be sensory 
loss followed by motor loss possibly leading to deformities. 
Histologically, tuberculoid lesions are well-defined 
granulomas with a central area of mature epithelioid cells 
surrounded by a large lymphocytic infiltrate. The granuloma 
must extend to the epidermis. Langhans1 giant cells may or 
may not be present and acid-fast stains seldom reveal 
organisms. Since the granulomas follow nerves, they are 
often elongated and organisms may be found in involved 
nerves (85,153).
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On the opposite end of the spectrum is the patient 
with lepromatous leprosy. Lepromatous leprosy is 
characterized by negative Fernandez and negative Mitsuda 
reactions. These patients have a nonfunctional CMI for M. 
leprae and large quantities of antibody may be found. The 
hypergammaglobulinemia seen in these patients includes 
heightened antibody response to many antigens, some 
probably related to M. leprae and varying amounts of 
autoantibodies (30,113)  ^ Clinically, these patients have 
many diffuse and symmetrical lesions which may be macular, 
papular or nodular. Papules and nodules tend to be of 
normal skin color, but macules are usually hypopigmented 
and have vague indistinct edges with a shiny surface.
Nerves are infected but not thickened in early lepromatous 
leprosy. Eventually there is hair loss and impaired 
sensation. Lesions may become infiltrated to distinct 
visibility and can progress to give characteristic leonine 
faces and madarosis seen in late lepromatous leprosy. 
Histologically, in lepromatous leprosy the epidermis is 
flattened and there is a clear zone separating the 
epidermis from the diffuse granulomatous infiltrate. The 
granuloma is composed primarily of macrophages with 
abundant vacuolated cytoplasm. These foamy macrophages are 
called lepra cells or Virchow cells. On acid-fast 
staining, many organisms are found inside these macrophages. 
Lymphocytes and plasma cells may be scattered in the
12
diffuse granuloma. Lymph nodes are often extensively 
involved (85,153)>
Between the two extreme poles of leprosy, there are 
gradations of the disease with the midpoint designated as 
mid-borderline (BB) or dimorphous leprosy. Clinically, 
there are a number of lesions which are anesthetic at the 
center but have well-defined inner borders and less 
distinct outer edges. Histologically there is a mixed 
infiltrate showing both histiocytes and epithelioid cells 
as well as numerous lymphocytes (85,153)e
Between borderline and tuberculoid, those borderline 
patients showing predominately tuberculoid features (but 
too disseminated to classify as TT) are termed 
borderline-tuberculoid (BT). The lesions are smaller and 
more numerous, and satellite lesions may be present. The 
edges of these lesions are less well defined than those in 
polar tuberculoid. Histologically, BT granulomas consist 
of epithelioid cells and lymphocytes forming a band in the 
dermis separated from the upper dermis by a clear 
area (85,153) .
The borderline lepromatous (BL) patient shows more of 
the features of lepromatous leprosy. Their plaquish 
lesions have an inverted saucer appearance with a sloping 
outer margin, a steep inner margin, and patchy anesthesia 
over some of the lesions. The histology of a BL lesion is 
that of focal collections of inflammatory cells - 
macrophages, lymphocytes, and epithelioid cells. Acid-fast
13
staining will reveal many bacilli within the 
macrophage (85,153),
Indeterminant (I) leprosy is considered the earliest 
clinical manifestation of the disease. There is usually a 
single macular lesion which is usually hypopigmented and 
rarely erythematous with indefinite edges. The histology 
of this lesion is nonspecific, having collections of 
mononuclear cells around skin adnexa, especially dermal 
nerves (85153),
Classification of leprosy is important for prognostic 
as well as treatment purposes. Classification is most 
accurate when based on histopathologic as well as clinical 
evaluation. In 19 82, Job and Chacko modified the 
Ripley-Jopling classification scheme to include a purely 
neural form described earlier by Dharmendra and to 
designate the mid-borderline (BB) condition as so uncommon 
and unstable as to represent a crossover point rather than 
a group in the classification (85),
Treatment;
Present treatment recommendations for leprosy are a 
combined regimen of dapsone, rifampin and clofazimine in 
patients with multibacillary disease and dapsone plus 
rifampin in patients with few bacilli or lesions (179),
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General leprosy immunology;
The lack of an antibody response in tuberculoid 
leprosy and the lack of a cell-mediated response in 
lepromatous leprosy has been termed split anergy. The 
split anergy of leprosy is an interesting immunological 
phenomenon and the mechanism of this anergy has been widely 
debated. Some have suggested that the defect of cell- 
mediated immunity in lepromatous leprosy is generalized or 
nonspecific (28,212)f while most feel the impairment is 
specific to M. leprae (18,38,52 151,213)(
Lepromatous patients are capable of mounting a high 
level of cellular resistance to other intracellular 
parasites (e.g., Leishmania braziliensis) (38)r and an 
increased incidence of other infections and tumors in 
leprosy patients is not seen (200)  ^ gtoner has suggested 
that leakage of bacilli into circulation at an early stage 
of infection might preferentially stimulate the central 
lymphon compartment while circumventing the peripheral 
lymphon compartment. He suggested that there is a 
subsequent development of suppressor cells rather than 
normal activation of the effector cells essential to 
establish CMI (193)t
Cell-mediated immunity relies on the interaction of 
macrophages, T lymphocytes, and possibly natural killer 
cells (207)# The split anergy of leprosy may be the result 
of some dysfunction in the communication of these cells.
M. leprae-induced impairment of the lymphocyte/macrophage
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interaction has been reported in patients with lepromatous 
leprosy (55), convit showed that macrophages of 
lepromatous patients could eliminate M. leprae when 
properly stimulated (39), such proper stimulation required 
a population of sensitized lymphocytes. Absence of these 
lymphocytes, either functionally or physically, could 
account for the inability of lepromatous patients to 
respond adequately to M. leprae antigens (53),
Considering the granulomas of leprosy, rhinoscleroma, 
and sarcoidosis, Modlin used monoclonal antibody to 
demonstrate two different patterns (121,122), Granulomas 
of tuberculoid leprosy and sarcoidosis had T helper cells 
thoughout the granuloma with T suppressor cells in the 
mantle of the lymphocytes surrounding the well-formed 
granuloma. Both helper and suppressor cells were diffusely 
scattered throughout the loose granulomas of lepromatous 
leprosy and rhinoscleroma. No surrounding mantle of T 
suppressor cells was present. It was postulated that the 
close association of T helpers and epithelioid macrophages 
in well-formed granulomas may reflect active cooperation to 
promote an effective immune response. The surrounding T 
suppressors may serve to contain the granulomatous reaction. 
The haphazard arrangement seen in the diffuse granulomas of 
lepromatous leprosy might reflect a relative inefficient 
host response that allows M. leprae proliferation. Van 
Voorhis has reported that T suppressor cells are scattered 
throughout the diffuse granulomas of lepromatous leprosy,
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and that T helper cells were present in the well-organized 
granulomas of tuberculoid leprosy (206), <r suppressor 
cells from lepromatous patients also failed to suppress 
normal B cell responses to the pokeweed mitogen, and B 
lymphocytes of lepromatous patients showed a higher mitogen 
response than normal controls or patients with tuberculoid 
leprosy (26,31),
While there is much evidence to indicate a T cell 
defect in lepromatous leprosy, splenic entrapment and 
inhibition of recirculation of lymphocytes might prevent 
their response to antigenic stimuli. Splenic entrapment of 
lymphocytes has been reported in the murine leprosy model 
(26), Two stages of splenic suppressor activity were also 
demonstrated in that model: early suppression was mediated 
by macrophages and late suppression was by T lymphocytes. 
Thus, the specificity and mechanism of the split anergy of 
leprosy is not well understood, but leprosy patients are 
markedly different from normal individuals and show great 
heterogeneity among themselves (26),
Reactions:
Leprosy patients also suffer a number of severe 
immunological reactions. An important focus of the 
immunology of leprosy is to develop methods that would aid 
in the management of these reactions. The reactional 
states of leprosy are broadly placed into two categories:
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type I lepra or reversal reactions, and type II lepra or 
erythema nodosum leprosum.
Reversal reactions (type I lepra) occur in patients in 
the nonpolar and polar extremes of the leprosy spectrum. 
These reactions are brought about by a change in the CMI of 
a patient (68,70,88). They are by nature type IV 
hypersensitivity reactions according to the Gell and 
Coombs' scale (41). Clinically, patients exhibit increased 
erythema and edema in existing skin lessions and swelling 
of nerves (37). Histologically, there is a shift in 
classification; treated patients undergoing reversal, by 
definition move toward tuberculoid and have increased 
lymphocytes in their granulomas with a decrease in the 
number of viable (solid-staining) and total acid-fast 
bacilli (68,70,88).
Also grouped with the type I lepra reactions is the 
so-called "downgrading" reaction of the borderline leprosy 
patient (68,70,88). clinical features here are similar to 
those for the reversal reaction and manifest as a delayed- 
type hypersensitivity (158,159). However, these patients 
are moving toward the lepromatous end of the spectrum.
The Akuter-Schub (acute panic) reaction is rare and 
occurs in the borderline lepromatous patient who is 
downgraded to lepromatous. With treatment, the patient has 
a slow upgrading until at some point the CMI is activated 
and the patient experiences multiple reversal reactions at 
sites where there is residual bacteria. This is a serious
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reaction, and results in multiple skin lesions and nerve 
involvement (68,70,88)^
Drugs used in suppression of reversal reactions are 
steroids and clofazimine (68,70)^
Type II lepra reactions occur in the lepromatous 
spectrum of leprosy. They are manifest in a rare event 
known as Lucio phenomenon or in the more common reaction 
erythema nodosum leprosum (ENL).. Lucio occurs only rarely 
and only in a specific sub-type of lepromatous leprosy, 
predominately in patients in Sinalou, Mexico. It is a 
severe complication of lepromatous leprosy characterized 
clinically by crops of irregular, stellate infarctions of 
the skin without nodular lesions (37)t These infarctions 
result in necrotic, ulcerated lesions which are sharply 
separated from the surrounding non-inflammed skin, and 
sloughing occurs. Lucio acts as a severe vasculitis of 
deep dermal vessels with thrombosis effectively cutting off 
blood supply leading to deep ulceration (68)#
Erythema nodosum leprosum (ENL) or type II lepra 
reaction is the most common complication of lepromatous 
leprosy and accounts for the majority of permanent sequelae 
in this disease type. Approximately 50% of lepromatous 
leprosy patients will experience ENL some time during the 
course of their disease. Although ENL usually occurs by 
the end of the first year of sulfone therapy, it may also 
manifest in the untreated patient. Therefore, ENL is 
considered a manifestation of the disease rather than a
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complication of therapy (150). ejjl can be triggered by 
intercurrent infections, vaccinations, pregnancy and 
physical or emotional stress (17,68,70,88). clinically,
ENL is characterized by crops of tender erythematous 
papules or. nodules on grossly uninvolved skin 
(37,68,70,88,149,200). ^he lesions are edematous and 
evanescent, lasting only 24 to 48 hours before spontaneous 
regression and may leave a faint bluish hyperpigmentation 
with slight desquamation of the surface (37,68 ,70,88)_ 
Eruption may be accompanied by general malaise, vague pains 
and an elevation in temperature. Lesions usually appear on 
the face, trunk, and extremities with the extensor 
surfaces of the limbs being favorite sites (68,70,87).
ENL exists in three phases (68,70,87). the acute phase 
(described above) is often accompanied by systemic symptoms 
of intermittent fever, polyarthralgia, polyneuritis, tender 
lymphadenopathy, iridocyclitis, and orchitis. This phase 
resolves in two to three weeks. In the subacute phase of 
ENL, crops of nodules recur at frequent intervals taking 
two to three months to resolve. In the chronic phase, 
nodules may continue to erupt with attacks lasting for 
several years. The patient with ENL will have an elevated 
sedimentation rate, a leukocytosis and proteinuria (37,212). 
Glomerulonephritis can be a complication of severe ENL. In 
severe episodes of ENL, lesions may become hemorrhagic, 
necrotic and ulcerated (68,70,87).
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ENL is viewed as a hypersensitivity reaction and 
inf lamination in the episode is considered of an allergic 
nature. Since ENL often occurs in the lepromatous patient 
during treatment, destruction of mycobacteria with a 
probable release of M. leprae antigens may be indicated in 
the pathogensis of the syndrome. Analogies have been made 
between ENL and the Jarisch-Herxheimer reaction frequently 
encountered in the treatment of syphilis (37) # 
Histologically, the lesions of ENL resemble those of the 
Arthus phenomenon with deposition of antigen-antibody 
complexes in vessel walls with resulting complement 
fixation eventuating in a leukocytoclastic vasculitis. An 
important characteristic of ENL is that there is no change 
in leprosy classification during the course of the reaction 
(68,70,212) f an<j there is no clinical evidence of extension 
of the disease or new lepromatous lesions (37) #
Recommended treatment for ENL are steroids, 
clofazimine, or thalidomide when not contraindicated
(15,68).
Pathogensis of ENL;
Erythema nodosum leprosum occurs only on a substrate 
of lepromatous leprosy (37,68,70)  ^ Patients with this form 
of leprosy demonstrate the immunological dichotomy of a 
split anergy having hypergammaglobulinemia with varying 
degrees of depressed CMI (170)# *rhe pathogenic mechanism 
for the initiation of ENL has not been described. Proposed
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mechanisms for the initiation of ENL may be divided into 
three broad categories: immune complexes (either tissue 
complexes or circulating immune complexes) with activation 
of classical complement pathways; activation of the 
alternate pathway of complement without participation of 
immunoglobulins; or some perturbation in control mechanisms 
at the cellular level (68,148)>
Lepromatous leprosy patients carry a high bacillary 
load which provides chronic antigen stimulation. ENL is 
often precipitated during treatment where the bacterial 
index (BI) and morphological index (MI) drop as the patient 
responds favorably to therapy. Chronic antigen stimulation 
in lepromatous patients provides a stimulus for continued 
antibody production. A cyclical production of antibody, 
particularly IgM, may result from such persistent antigen 
stimulation (68,70,212)  ^ polyclonal immunoglobulinemia has 
been observed in leprosy patients both with and without ENL. 
New patients also tend to present with elevated 
immunoglobulin levels. IgM-type antibodies may decline 
with treatment, while IgG- and IgA-type antibodies may 
remain elevated (30,68,70,170,216)#
Because the histological picture of ENL is so similar 
to that of the Arthus phenomenon, it has long been 
postulated that ENL is mediated by the deposition of 
antigen/antibody complexes and subsequent activation of the 
classical complement pathway. ENL also has systemic 
features very like that of serum sickness, suggesting the
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presence of circulating immune complexes d 7 >. An early 
indication of immune complex formation was provided by the 
demonstration of cryoglobulins in lepromatous patients 
(113)4 Cryoglobulins were present in 97% of those without 
ENL, 100% of those with untreated ENL, and 58% of those 
with ENL on steroid therapy. These cryoglobulins were 
shown to be of a mixed type and anti-IgG activity was 
demonstrated in the IgM component (18). It was postulated 
that autologous IgG may become autoantigenic following 
reaction with a primary antigen. This altered IgG may then 
stimulate the host immune system to respond by producing a 
corresponding IgM antibody. These complexes (IgG plus 
anti-IgG -IgM) could then be instrumental in the induction 
of ENL (18).
Deposits of immunoglobulin and complement have been 
demonstrated by immunofluoresence in the lesions of 
approximately 55% of ENL patients (212,214)  ^ depOSits
were perivascular and located in areas corresponding to the 
infiltration of polymorphonuclear neutrophils (PMNs). 
Soluble mycobacterial antigen was detected in some of these 
complexes, which were sometimes located within the walls of 
blood vessels. It was suggested that the lesions of ENL 
are caused by these complexes, either formed locally 
(Arthus) or present in the circulation.
Deposits of immunoglobulin alone have been 
demonstrated in the skin of lepromatous
patients (29,73,147)# Specific, fine granular deposits of
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IgM have been detected at the dermal-epidermal junction(29) 
and also in the dermal collagen and elastic fibers of 
lepromatous patients (147)_ t WO possibilities were 
suggested for the etiology of these deposits: tissue-bound
IgM may be specific antibody to mycobacterial antigens, or 
anti-mycobacterial antibody may cross react with basement 
membrane antigen. More recently, skin biopsies from 
reactive nodular lesions were shown to contain IgG (100%) 
as well as IgM (58%) in deposits at the dermal-epidermal 
junction <73)# it is still not known if these deposits are 
specific antibodies to mycobacterial antigens or 
autoantibodies.
Circulating immune complexes have been detected in the 
sera of leprosy patients by Clq precipitation in 
gel (122,160)  ^ presence of these complexes was shown to 
correlate with the clinical condition; complexes were 
present in 33-70% of the lepromatous patients without ENL, 
76% of the lepromatous patients with active ENL, 20% of the 
tuberculoid patients, and only 3% of normal controls. It 
was suggested that localized complexes might mediate the 
ENL lesions (Arthus), while circulating immune complexes 
might be associated with the systemic symptoms of ENL. Clq 
precipitation and gel assays are not without controversy. 
Tung and associates have demonstrated that Clq also reacts 
with DNA and bacterial antigens - the results of such tests 
for the detection of immune complexes should be interpreted 
with caution in patients with infectious diseases <201),
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Clq binding assays do not give false-positive reactions 
with organisms or DNA (104), using these methods, it has 
been shown that circulating immune complexes exist in the 
sera of 82% of leprosy patients with uncomplicated 
lepromatous leprosy, 80% of lepromatous patients with ENL, 
and 58% of tuberculoid patients (16), Differences also 
exist between leprosy patients in endemic and nonendemic 
areas (205), jn endemic areas, patients across the leprosy 
spectrum can demonstrate circulating immune complexes. 
Circulating immune complexes are not demonstrable in TT and 
BT patients from non— ndemic areas. Thus, circulating 
immune complexes are probably neither specific for ENL nor 
related specifically to leprosy. Reliable interpretations 
of immune complexes in leprosy patients will probably only 
be available when examinations are made using antigens 
specific for M. leprae.
Using C3d levels as a measure of complement catabolism 
evidence for increased complement activation in patients 
with ENL has been reported (16,205), t w o  sources of C3d 
were postulated: immune complexes or C3d fragments 
diffusing from extravascular sites of immune complex 
deposition and complement activation (16), During ENL, C3d 
levels were high but returned to normal once the clinical 
signs of ENL had subsided (205), Thus, it was suggested 
that ENL lesions are mediated by complement and that 
elevated C3d levels are highly specific for ENL.
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Londono (109) found C3d deposits in vessel walls, but 
was unable to demonstrate immunoglobulin and suggested that 
the alternate pathway of complement played an important 
role in ENL. Other investigators have noted a fall in the 
C3 level and an elevation in the Ba {breakdown product of 
factor B) in ENL (168). These workers proposed that during 
the initial phase of acute ENL there is a sudden release of 
M. leprae antigens into circulation which first initiates 
the classical complement pathway and, subsequently, the 
alternate complement pathway. Overall, there is little 
agreement about the role of complement in the initiation of 
ENL.
Mshana, et al. (126) found mycobacterial antigen in 
all biopsies from lepromatous patients {with or without 
ENL), while only 23% of ENL patients were positive for 
immunoglobulin or complement deposits. Both ENL and 
lepromatous patients without ENL had foamy,macrophages 
with large amounts of mycobacterial antigen. In ENL, these 
macrophages were said to rupture and release antigens into 
the extracellular spaces. Absence of immunoglobulin and C3 
in the presence of extracellular antigen in ENL was taken 
to indicate that mycobacterial antigen is more important 
than antigen-antibody complexes for the initiation 
of ENL (158,159).
The presence of large quantities of M. leprae antigens 
provides chronic stimulation to the partially responsive 
immune system of lepromatous patients. Turk has suggested
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that the continued stimulation of these cells might induce 
a population of B suppressor cells capable of modulating T 
cells, as well as those that develop into conventional 
antibody producing cells (200), Bach (9) an<j Wallach (209) 
used monoclonal antibodies to show that lepromatous 
patients with recent ENL have a decreased number of T 
suppressor cells in the peripheral blood and an increased 
number of T helper cells. In mixed lymphocyte cultures 
these cells were noted to have an elevated response to 
mitogen. The helper/suppressor ratio was normal in both 
tuberculoid patients and nonreactional lepromatous patients.' 
It was postulated that the imbalance between T cell subsets 
contributed to the occurrence of ENL in lepromatous 
patients. Later, Mshana (125) showed an increase in T 
suppressors and the peripheral blood of lepromatous leprosy 
patients and a transient acute inversion of the 
helper/suppressor ratio during ENL. The transient decrease 
in T suppressors could be due either to decreased 
production of T suppressors or to increased sequestration 
of those cells in tissues (161), The mechanism by which 
these cells may affect regulation in ENL is as yet unknown. 
However, other cell types seem to be affected during ENL. 
Cytotoxic T cells have been shown to be defective in 
lepromatous patients without ENL and to become functional 
in patients during ENL (189). This deficiency could be 
either part of a reactional process or part of the 
underlying T cell abnormality of lepromatous leprosy.
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Humphres, et al. (76) has described depressed natural 
killer (NK) cell activity in ENL patients, and the 
patients' own monocytes were seen to be responsible for the 
depression of NK activity.
The various theories as to the induction of ENL are 
not mutually exclusive, and a number of mechanisms may 
interact. Regardless of the exact sequence of events and 
whether ENL is cellular or immune-complex initiated, the 
common denominator is the presence of PMNs in ENL lesions. 
It is obvious that this is the cell that directly mediates 
the tissue damage. What is not known is the mechanism by 
which PMNs are recruited.
Thalidomide has been shown to be effective in the 
treatment of ENL. Understanding the mechanism of action of 
thalidomide in halting the immunological and/or 
inflammatory events in ENL might lead to a better 
understanding of the immunopathology of ENL reactions. 
Thalidomide has been shown to prevent PMN chemotaxis
(13,69)f to stabilize lysozomal membranes, and to 
antagonize certain chemical mediators of inflammation 
(histamine, serotonin, acetylcholine, and prostaglandin E-2 
and F-2 alpha) (71), Therapeutic doses of thalidomide 
decrease the generation of toxic oxygen intermediates by 
PMNs (120)# Shannon (176) demonstrated a selective 
decrease in IgM in leprosy patients during treatment of ENL 
with thalidomide, as well as an inhibition of de novo IgM 
synthesis in mice. It was proposed that IgM antibody is
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the relevant immunoglobulin-initiating immune complex 
formation in ENL. Recent studies using the T-independent 
antigen DNP-Ficoll suggest that thalidomide either has no 
effect or slightly augments the IgM antibody response to 
this antigen. Therefore, thalidomide appears to 
selectively suppress the IgM response to T-dependent 
antigens (175). IgM is primarily intravascular (80%) and 
the maximum complement fixing ability of IgM and soluble 
antigen/antibody complexes is formed when the antibody is 
in excess. Therefore, favorable conditions for a type III 
hypersensitivity reaction with IgM and complement fixation 
occur intravascularly. Complex formation at the vascular 
epithelium can first occur as antigen diffuses from tissue 
spaces (32)  ^ initial vascular damage occurs
permeability increases, allowing penetration of IgM into 
the vessel wall since more complexes may form as more 
antigen is encountered. Perhaps only when ENL is examined 
in the light of antibodies, antigen and immune complexes 
specific for antigens of M. leprae will the pathogenesis of 
the reaction be understood.
Serology:
Resistance to leprosy is primarily dependent on the 
cell-mediated immune system, but M. leprae does stimulate 
an apparently nonprotective humoral response (1/203)# 
Serology holds hope to aid the early diagnosis and 
management of leprosy cases. Antibody levels in leprosy
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patients have been reported to reflect the different 
clinical forms of the disease (91) an(j to change with 
alteration of the antigen load in chemotherapy (91,152,197)^ 
A good review of serological attempts in leprosy has been 
prepared by Melsom (130)# Generally, complement fixation, 
passive hemagglutination, double diffusion in gels, 
indirect immunofluoresence (IFA), gel precipitation, 
radioimmunoassay (RIA), and enzyme-linked immunosorbent 
assays (ELISA) have been used to detect antibodies in 
leprosy patients.
Complement fixation tests were introduced for the 
diagnosis of several infectious diseases around 1900.
Eitner (46) showed that antigen preparations from human 
lepromas could fix complement with sera from leprosy 
patients. Sera from lepromatous leprosy patients showed 
high reactivity in the complement fixation tests, while 
sera from tuberculoid patients showed poor or no reactivity 
(46) _ Based upon these and similar findings using 
different test systems for antibodies in sera from leprosy 
patients, paucibacillary tuberculoid leprosy patients have 
been classified as "poor antibody responders" and patients 
with multibacillary lepromatous leprosy, "good antibody 
responders" (26)  ^ This antibody response is also reflected 
in increased immunoglobulin concentration (40) an£ j.n 
increased frequency of autoantibodies, like rheumatoid 
factors, anti-thyroid antibodies, and anti-nuclear 
antibodies (149), Additionally, components from several
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mycobacterial and diphtheroid species could fix complement 
with sera from leprosy patients (40). Therefore, the test 
lacked specificity and only had use in diagnosis of 
lepromatous leprosy (41,45)#
Mycobacterial antigen-antibody reactions were first 
examined by hemagglutination tests in 19 48 (119)# sheep 
red blood cells {SRBC) were found to be the best carrier 
cells ^39)  ^ and better results were obtained when SRBC 
were sensitized with M. tuberculosis than with M. 
leprae Low positive titers often resulted in sera
from normal controls. Higher titers were noted in 
tuberculoid leprosy patients, and the highest titers were 
manifested by lepromatous leprosy patients (106). More 
recently, there have been attempts to coat tanned SRBC with 
M. leprae from armadillos. Specificity was enhanced by 
absorption of test sera with M. tuberculosis and M. vaccae. 
Absorbed lepromatous sera still contained antibodies which 
agglutinated the red. blood cells (83) ^ However, these sera 
also reacted with M. lepraemurium, M. bovis, M. phlebesin, 
M. gastri, M. gordonae and M. nonchromogenicum by 
immunodiffusion methods (162)^ jn some lepromatous leprosy 
patients a decrease in titer was found in sera taken some 
months after sulfone treatment was begun (162)^ 
increase in titer could also be demonstrated when sera were 
taken during an ENL reaction (42). The hemagglutination 
test primarily confirmed the previous findings from the
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complement fixation test but also lacked specificity in its 
determinations.
The Rubino reaction was described in 1926 as a 
sedimentation reaction between formalin-treated SRBC and 
sera from leprosy patients. Sera from patients with 
diseases other than leprosy could not sediment such treated 
SRBC (43,166)# The Rubino test was mostly positive with 
sera from lepromatous patients and negative with sera from 
tuberculoid patients. Until recently, the test has been 
used in Latin America. However, the Rubino reaction can be 
inhibited by antigens from several mycobacterial species 
and is positive during renal failure (5,164)  ^ The test is 
not specific for M. leprae, and the value seems limited.
Gel precipitation methods were first applied using 
lepromin and serum from lepromatous patients in 1957 (138)  ^
This technique, applied in double diffusion schema and 
crossed Immunoelectrophoresis, has been used extensively in 
the characterization of antigens of M. leprae. These 
methods indicate that leprosy patients may respond 
differently to a number of cross reactive antigens of M. 
leprae. Diffusion techniques are not suitable for 
quantitation of antibody reactions, and the heterogeneity 
of patient response make them unsuitable for the diagnosis 
of leprosy and will not be discussed.
The indirect fluorescent antibody (IFA) technique was 
first used to demonstrate antibodies to M. leprae and M. 
tuberculosis in 1961 (128)  ^ Leprosy patients had positive
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reactions with both M. leprae and M. tuberculosis. The 
technique was further developed by Abe jjo aid
specificity, Abe applied a series of absorbtions with 
cardiolipin, lecithin, BCG, and M. vaccae. After 
absorbtion, diluted serum was applied to smears of M. 
leprae obtained from leprosy patients or armadillos 
To enhance reaction by removal of lipids and exposing 
protein antigens, smears were treated with
carbon-tetrachloride and trypsin. Reading was accomplished 
with a special combination of fluorescent filters and based 
on the amount of total fluorescence emitted by a single 
organism. Antibodies were detected in 100% of the 
lepromatous leprosy patients and 80% of the tuberculoid 
patients. Antibodies were not detected in normal control 
groups but were found in household contacts. The IPA test 
was also modified for use and presumptive identification of 
M. leprae organisms (114)^ Recently, it has been shown 
that sera absorbed by the scheme of Abe could also react 
with M. lepraemurium, M. bovis, M. nonchromogenicum, M. 
phlebesin, M. gordonae and M. gastri <49)# Therefore, 
exposure to environmental mycobacteria and BCG may have 
influence on the results of these studies. IFA is not 
specific for M. leprae, and interpretations are subjective. 
The test has not received wide application in other 
laboratories.
Radioimmunoassay (RIA) has been used both 
competitively and in solid-phase assays with antigen
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systems not specific for M. leprae. The first RIA in 
leprosy used the antigen 60 from BCG. Antibodies were 
detected in 25 of 29 lepromatous patients and in 11 of 20 
tuberculoid patients. However, BCG vaccination is in wide 
use and antibodies to this antigen would not be reliable 
indicators of leprosy infection (63). using gel diffusion 
to examine the sera of leprosy patients, Harboe noted a 
specific line of precipitation more commonly formed by 
reaction with fractions of sonicated whole M. leprae.
Using this antigen 7 mixture in RIA, antibodies were 
detected in 80% of the lepromatous patients and 
occasionally detected in tuberculoid patients (66).
Levels of antibodies in lepromatous patients were noted to 
fall after the first year of dapsone therapy (135). jn 
examining the sera from armadillos, antibodies to antigen 7 
became detectable in experimental infections with M. leprae 
only after establishment of the disseminated infection (49). 
Owing to the mixture of antigens in the preparation, it was 
again necessary to absorb test sera with other 
mycobacterial species to enhance specificity (64). 
this time it is uncertain if the absorption scheme 
adequately removes all cross reacting antibodies with M. 
leprae. The requirements for absorption may vary in 
different populations depending on the mycobacterial flora 
(130). while the originial RIA was designed using 
Staphlococcal protein-A as a precipitant of antibodies 
reacting with iodinated fractions of whole M. leprae, the
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assay has been modified for use in solid-phase analysis.
The solid-phase method allows distinction of antibody 
isotypes (127,128,129,130), Antibody activities of 
different patient sera varied widely. IgM antibodies for 
antigen 7 are highest in early lepromatous leprosy and 
decline over term (134), Antibodies were less often 
detected in tuberculoid patients. IgG and IgA antibodies 
tend to decrease over term with sulfone therapy C133> _
Thus, IgM antibodies for antigen 7 are probably more 
appropriate for early diagnosis of sub-clinical leprosy, 
and other isotypes probably more responsibly indicate the 
effect of therapy (132,134,135), The preparation of 
suitable amounts of M. leprae antigen 7 has been difficult 
and different batches tend to yield different results (126), 
The requirements for absorption of sera also gives the 
antigen questionable specificity, and assays using more 
specific antigen preparations are needed (60,61,99),
The phenolic-glycolipid-1 antigen is chemically 
defined and readily available from the tissues of 
experimentally infected armadillos (21,77), Although its 
phthiocerol core is shared with M. kansasii, cross 
reactions with the specific trisaccharide epitope have not 
been described (33), The nonaqueous nature of this antigen 
originally complicated immunologic investigations. To 
demonstrate antigenicity in gel diffusion assays required 
incorporation into liposomes (22,141), Although 
complicating other aspects, this hydrophobicity especially
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recommends the antigen as an immunosorbent in solid-phase 
assays. Organic solvents and detergents were not useful in 
dispersing phenolic-glycolipid-1 to solid phases. They 
either reacted with the sorbent material or would not 
release the antigen for hydrophobic binding-(78)#
Dispersing the antigen, either by deacylation of its lipid 
side chains or sonication of the native lipid, proved most 
successful and today, a number of investigators have 
developed ELISA assays (44,107)  ^ this time, most
reports in the literature concern the specificity of the 
antigen. The specificity of the antigen lends well to 
sero-epidemiologic studies, and there is hope that the 
antigen may be used in the early serodiagnosis of leprosy 
(20,24)' phenolic-glycolipid-1 also offers a unique 
opportunity to examine M. leprae-specific humoral responses 
in leprosy patients. The following studies use this 
antigen as a mechanism to examine M. leprae-specific 
humoral responses in leprosy patients and in armadillos for 
both sero-epidemiology and management.
CHAPTER 3
DETECTION OF IgM CLASS ANTIBODIES 
IN ARMADILLOS 
TO THE PHENOLIC-GLYCOLIPID-1 ANTIGEN OF M. LEPRAE. 
1. DEVELOPMENT OF A SEROLOGIC TEST
Richard W. Trumanl'2r Edward J. Shannon2, and 
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Chapter 3: Abstract
An enzyme-linked immunosorbent assay (ELISA) using 
antisera specific for human IgM and the phenolic- 
glycolipid-1 (Phen-Gl-1) antigen of M. leprae has been 
developed for immune status assessment of armadillos.
Human and armadillo IgM express sufficient serologic cross 
reactivity to allow the use of commercially prepared 
anti-human IgM to detect armadillo IgM antibodies. Testing 
plasma from 76 armadillos having a known experimental 
inoculation history with M. leprae showed the assay to have 
high sensitivity and specificity. IgM anti-Phen-Gl-1 
antibodies were detected both before and after the 
appearance of acid-fast bacilli in peripheral blood, buffy 
coat cells of experimentally infected armadillos, and up to 
36 months after the experimental infection. Armadillos not 
experimentally infected with M. leprae (4/20) also had 
detectable IgM antibodies to Phen-Gl-l. These antibodies 
were absorbable with whole M. leprae, suggesting that wild 
armadillos may have an antibody prevalence rate as high as 
20%. The assay has application for sero-epidemiology and 
the monitoring of experimental infections with M. leprae in 
armadillos.
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The nine-banded armadillo (Dasypus novemcinctus) is 
the most common host for the in vivo propagation of 
Mycobacterium leprae (97) an(j an animal model for the
study of leprosy (194)> Captive breeding of armadillos is 
generally unsuccessful, and animals must be taken from the 
wild for use in scientific studies. Wild armadillos have 
been reported to harbor a mycobacterial infection that is 
indistinguishable from M. leprae (210) # rp0 avoici 
contamination of cultured strains and assure similarity of 
immunological responses in model systems, recently captured 
animals must be screened to assess their naivetd to M. 
leprae.
Serology is a traditional means of screening animals 
for infectious experiences, but the serology of M. leprae 
has been most difficult. M. leprae bears a number of 
antigens which cross react with other mycobacterial species 
(103,136)_ The insectivorous, burrowing armadillo 
habitually encounters a wide variety of common soil 
mycobacteria and likely develops antibodies to many cross 
reacting antigens of M. leprae. previous serological 
assays for M. leprae antibodies in armadillos have utilized 
traditional Staphylococcal-A radioimmunoassay methodologies 
with iodinated fractions of the sonicated whole leprosy 
bacillus (64,66)# consequently, they lacked both 
specificity and the ability to distinguish antibody 
isotypes (179). Recently, a chemically defined phenolic 
glycolipid antigen (Phen-Gl-1) of M. leprae has been
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isolated from the tissues of experimentally infected 
armadillos. The antigen has not been found in other 
mycobacterial species and is apparently specific for M. 
leprae (22,33,78)# others have reported the development 
and utilization of enzyme-linked immunosorbent assays 
(ELISA) for antibodies to Phen-Gl-1 in human sera (24,78)  ^
We report here the development of an ELISA that detects 
IgM-class antibodies in armadillo serum reacting with the 
Phen-Gl-1 antigen of M. leprae.
MATERIALS AND METHODS
Anti-armadillo serum: Rabbit anti-armadillo serum
globulins was a gift of Dr. T. E. Wilson, University of 
Southeastern Louisiana (Lafayette, Louisiana).
CIEP: Crossed immunoelectrophoresis (CIEP) was
performed by the method of Clark and Freeman (34)> Serum 
was electrophoresed in 1% agarose gel with 0.025 M tricine 
buffer, pH 8.6, with constant voltage of 20 volts/cm 
(BioRad 3000/300, Richmond, CA). Electrophoresis proceeded 
for 50 min in the first dimension when a second slab was 
cast that contained either second antibody conjugate or 
anti-armadillo immunoglobulins. Electrophoresis was 
performed in the second dimension for 60 min before the 
slabs were washed in normal saline and stained with 
Coomassie blue to visualize antibody reactions.
Antigen: Native purified phenolic glycolipid-1
(Phen-Gl-1) was prepared by Dr. Patrick Brennan (Colorado
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State University) and obtained through contract with the 
National Institute of Allergy and Infectious Diseases (Dr. 
Darrel Gwinn, project Officer).
Experimentally infected control group; Armadillos 
at the National Hansen's Disease Center are captured from 
the wild and housed for the production of M. leprae. They 
are periodically bled, both pre- and post-experimental 
inoculation with M. leprae, to examine for the presence of 
acid-fast bacilli in peripheral blood, buffy coat cells. 
Plasma from these bleedings is separated and stored at 
-80°C for future use. Seventy-six such samples were used 
for this study. Twenty of the samples were from animals 
before inoculation with M. leprae; one of the 20 was from 
an armadillo originally presenting from the wild with an 
acid-fast bacterial infection that was indistinguishable 
from that caused by M. leprae in that the bacilli oxidized 
D-DOPA (144,145) an(j their acid fastness was extracted with 
pyridine (H5). The remaining 56 samples were from 
armadillos that had been inoculated with M. leprae from 4 
to 43 months before bleeding. Thirty-one of the 76 
armadillos had acid-fast bacteremia at the time of bleeding. 
Two of these 76 sera were from animals that had resisted 
challenge with M. leprae, as shown by having no signs of 
infection 28 months after inoculation with at least 1 x 10® 
viable leprosy bacilli.
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ELISA;
ELISA-IqM vs. Phen-Gl-1; An enzyme-linked 
immunosorbent assay (ELISA) was performed according to the 
method of Voller and Bidwell (79). Specifically, native 
phenolic-glycolipid-1 (Phen-Gl-1) was mixed with 0.05 M 
carbonate buffer, pH 9.5, and suspended via sonication with 
a 3 mm probe at 70 watts for 1 minute (Ultrasonics, Inc., 
Plainville, NY). The suspended antigen was diluted in the 
same buffer to a concentration of 2 jag in 50 jul the volume 
which was added to each well of a 96 well polyvinyl flat 
bottom microtiter plate (Cooke Labs, Alexandria, VA). The 
plates were sealed with Parafilm (American Can Co., 
Greenwich, CT) and incubated over night at 37°C in a water 
bath. After incubation, the wells were washed 3 times for 
5 minutes each wash with 200 jul of wash buffer consisting 
of 0.067 M phosphate-buffered saline (PBS), pH 7.2, 
containing 1% bovine serum albumin (BSA) (Fraction V;
Sigma, St. Louis, MO). After washing, the wells were 
blocked by the addition of 100 jal of 0.0 67 M PBS, pH 7.2, 
containing 5% BSA and incubated at 37°C for 1 hr. The 
wells were then washed as before and 50 jal of each serum 
sample diluted in wash buffer was added to duplicate wells 
in an effective dilution of 1:180. The plates were sealed, 
and incubated at 37°C for 1.5 hr when they were removed, 
and washed as before. Horseradish peroxidase conjugated 
IgG fraction of goat anti-human IgM (mu specific) (Cappel, 
Cochranville, PA) optimally diluted (1:4000) in 50 jil of
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wash buffer was added to each well. The plates were then 
sealed and incubated for 2 hr at 37 °C, when they were 
removed and washed as before. After washing, 50 jul of a 
solution containing 0.4 mg/ml ortho-phenylene-diamine with 
0.002% H2O2 in 0.1 M sodium acetate buffer, pH 5.5, was 
added to each well. The plates were incubated at room 
temperature for 20 min when the reaction was stopped with 
the addition of 50 jul 9 N HCl. The plates were read for 
absorbency at 488 nm on a Beckman DU8B spectrophotometer. 
Control absorbent values from wells containing serum but 
not receiving antigen were subtracted from serum plus 
antigen wells. The mean absorbent value for each sample 
was calculated for use in statistical analysis.
Optimal dilutions; The optimal dilution of serum 
was defined to be that lowest dilution which did not yield 
nonspecific absorption greater than 2 times the substrate 
control when reacted in blank wells. Serum was diluted 
1:100, 1:400 by two-fold dilutions in the ELISA wash buffer 
and reacted with an optimal dilution (1:4000) of conjugate 
(see below).
The optimal concentration of the.M. leprae Phen-Gl-1 
antigen was determined by checkerboard titration. Positive 
and negative armadillo sera were selected on the basis of 
known inoculation history with M. leprae. Conjugate and 
sera were used at constant dilutions in an ELISA wash 
buffer at 1:4000 and 1:180, respectively. The Phen-Gl-1 
antigen was coated in microtiter plates at concentrations
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of 100 ug/ml with two-fold dilutions to 3 jig/ml. Coating 
and incubations were followed as described before. The 
optimal concentration was defined as that highest dilution 
in antigen excess resulting in the greatest difference in 
absorbency readings between positive and negative sera.
To determine the optimum range of conjugate for use in 
the assay, the conjugate, horseradish peroxidase IgG 
fraction of goat anti-human IgM (mu specific), was diluted 
two-fold from 1:100 to 1:32000 in an ELISA wash buffer. A 
checkerboard titration was performed across the wells of a 
polyvinyl microtiter plate coated with serial dilutions of 
human IgM (Cappel, Cochranville, PA) at 100, 50, 10, 5, 1, 
and 0.1 ng/well. Following incubation and wash procedures 
as described above, the optimum range was defined as those 
dilutions of conjugate yielding best linearity in 
absorbency readings between 1 and 10 ng of human IgM. 
Optimal dilution of conjugate was later determined in 
checkerboard titration across the wells of a polyvinyl 
microtiter plate coated with 50 jug/ml of Phen-Gl-1 and 
reacted with positive and negative serum as delineated 
before. The optimal dilution of conjugate was defined to 
be the highest dilution which also yielded the greatest 
difference in absorbency readings between the positive and 
negative sera.
Mycobacterial species: Cultivable mycobacterial
species (M. scrofulaceum, M. phlei) were inoculated to 
Lowenstein-Jensen (L-J) slants and grown to confluency.
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The organisms were harvested using Hanks1 balanced salt 
solution (HBSS) and pelleted via centrifugation 2000 x g 
for 10 minutes. They were subsequently washed 5 times with 
HBSS and enumerated (182). ^he organisms were aliquoted to 
separate tubes such that each tube contained 1 x 1 0 9 
bacteria. They were pelleted by centrifugation and the 
supernatants discarded. M. leprae were propagated in 
armadillos and harvested from tissues by manual teasing 
into 1 gm pieces. Tissue and bacteria were separated by 
differential centrifugation in HBSS and the supernatants 
were saved. Supernatants containing M. leprae were then 
pelleted by centrifugation and washed 5 times with HBSS. 
Organisms were enumerated and aliquoted to separate tubes 
such that they would contain 1 x 1 0 9 M. leprae after 
supernatants were removed.
Absorption of sera; Selected serum samples were 
absorbed with the mycobacterial species. Sera diluted 
1:180 in 400 jul of ELISA wash buffer were added to the 
tubes containing 1 x 109 pelleted mycobacteria. Pellets 
were resuspended by gentle shaking every 15 min while the 
tubes were incubated for 1 hr at 37°C. The tubes were then 
held overnight at 4°C, and the suspensions were clarified 
by centrifugation before use. The absorbed supernatant 
serum was then assayed by the ELISA as described previously.
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RESULTS
Cross reactivity of human and armadillo IgM;
Human IgM and armadillo IgM are serologically cross 
reactive. Crossed immunoelectrophoresis (CIEP) of 
armadillo whole serum into a second dimension containing 
rabbit anti-armadillo globulins produced a typical CIEP 
pattern with multiple lines of precipitation (Fig. 3.1a). 
While CIEP into a second dimension containing peroxidase 
conjugated goat anti-human IgM (mu chain specific) 
demonstrated a single precipitation line of slow migration 
like that of IgM (Fig. 3.1b), other armadillo serum 
proteins were not detected with the anti-human IgM 
peroxidase conjugate.
Optimization of ELISA; For the ELISA, the lowest 
serum dilution was selected which did not result in 
excessive nonspecific binding of immunoglobulins to the 
carrier surface. As shown in Figure 3.2a, serum dilutions 
less than 1:180 resulted in nonspecific binding to the 
solid phase > 2.5 times the substrate control. Sera 
diluted 1:180 avoided this nonspecific binding and was 
selected as optimal.
Optimal proportions of antigen and antibody aid in the 
sensitivity of the assay. As shown in Figure 3.2b, coating 
wells with 2 jug of Phen-Gl-1 resulted in antigen excess 
while allowing maximum dilution of the antigen in the 
system.
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A maximum conjugate dilution of 1:4000 yielded the 
greatest difference of absorbency readings between positive 
and negative samples {Figure 3.2c). This dilution did not 
result in nonspecific absorption of conjugate to the solid 
phase. This conjugate dilution also showed linearity of 
reaction between 1 and 10 ng of human IgM (data not shown).
ELISA of control group: Seventy-six plasma
samples from armadillos housed at the National Hansen's 
Disease Center armadillo farm were assessed. The results 
are illustrated in a frequency histogram (Figure 3.3a) and 
a scattergram (Figure 3.3b). When the sample was examined, 
over 10 equal class intervals of 200 absorbent units each, 
an apparent bi-modal distribution was revealed (Figure 
3.3a). When the population was more closely scrutinized in 
a scattergram, the apparent separation in absorbency 
readings along the continuum creating two groups was shown 
to be distinct. Multivariate discriminant analysis showed 
this separation to be statistically significant (p < 0 .0 0 1 ; 
N=52, N=23) (36,192) (Fig. 3.3b). The boundaries of the 
two groups as demarked by two standard deviations around 
their respective means created an equivocal zone. It was 
considered that points falling within the equivocal zone 
could not reliably be ascribed to either of the two groups.
The data points were then pooled and analyzed 
according to their known experimental inoculation history 
with M. leprae (i.e., months post-inoculation) and 
appearance of acid-fast bacilli {AFB) in peripheral blood,
47
buffy coat cells. Points falling above the equivocal zone 
were predominantly (48/52) from armadillos known to have 
been experimentally inoculated with M. leprae (Figure 3.4). 
All samples from armadillos with acid-fast bacteria in 
their buffy coat smears appeared above the equivocal zone. 
Of those points falling below the equivocal zone, 16 of 23 
animals were not experimentally inoculated with M. leprae, 
while the remaining 7 were known to have been inoculated 
with M. leprae. One animal was considered to be resistant 
to the infection. The single point falling within the 
equivocal zone also was derived from an animal considered 
resistant. Thus, the points falling above the equivocal 
zone represent sera from animals with detectable IgM 
antibodies to Phen-Gl-1, and were considered "positive". 
Those below the zone did not have detectable IgM antibodies 
to Phen-Gl-1 and were considered "negative". Animals not 
manifesting AFB appear on both sides of the zone, while 
those demonstrating AFB grouped only above the zone. 
Regressional analysis was performed for AFB positive and 
AFB-negative animals with time after experimental 
inoculation. Both groups regressed significantly and their 
slopes appeared to be different, showing the ELISA to be 
semi-quantitative and suggesting a difference in the rates 
of antibody development in the two groups.
Four armadillos not experimentally inoculated with M. 
leprae also appeared in the positive group. One of these 
armadillos presented from the wild with an acid-fast
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bacterial infection indistinguishable from M. leprae. 
Absorption of these four sera with whole M. leprae 
significantly reduced <p = 0 .0 0 1 , paired t test) the 
antibody reactivity. Absorption with M. scrofulaceum and 
M. phlei did not significantly alter the antibody 
reactivity of these sera {Figure 3.5).
ELISA IgM vs. Phen-Gl-1 quality parameters: The
serological parameters of sensitivity, specificity, 
efficiency, and predictive value for positives (79) Were 
calculated for the ELISA IgM vs. Phen-Gl-1 based on the 
available data. As shown in Table 3.1, the assay correctly 
detects IgM antibodies in an armadillo with a known 
previous experience with M. leprae 100% of the time 
{predictive value of positive). With a 95% confidence, the 
assay offers a sensitivity of 89%, a specificity of 100%, 
with an overall efficiency of correctly identifying the 
infectious experience of an armadillo 90% of the time.
DISCUSSION
These data indicate that an enzyme-linked immunosorbent 
assay incorporating cross reactive antisera for human IgM 
and the Phen-Gl-1 antigen correlates with, and therefore 
may be used to assess the immunological experience of 
armadillos with M. leprae. The ELISA-IgM vs. Phen-Gl-1 
avoids problems of nonspecific reactivity found in assays 
using undefined antigen mixtures, and allows detection of
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IgM class antibodies to M. leprae. The assay is an 
efficient (90%) tool for serological investigations of M. 
leprae in armadillos, and affords sensitivity (89%) and 
apparent specificity (1 0 0%) heretofore unreported for 
serological assays in leprosy (196),
Serological cross reactivity of human IgM has been 
noted in several other species including cows, monkeys and 
sharks (74), use of commercially prepared reagents in 
immunoassays allows for their wider application in other 
laboratories. Armadillo antisera are not commercially 
available, but armadillo IgM has substantial serological 
cross reactivity with human IgM. Fortunately, therefore, 
commercially prepared anti-human IgM second antibody enzyme 
conjugates are satisfactory for use in ELISA assays for 
armadillo IgM antibodies.
Serological screening tests must distinguish samples 
as positive or negative. To do so, the descriptive limits 
of positive and negative must be defined and the assays 
must be optimized to avoid nonspecific reactivity. By 
screening sera from 7 6 armadillos of known inoculation 
history with M. leprae, statistical limits for positive and 
negative have been derived for the ELISA IgM vs. Phen-Gl-1. 
Sera from this group may now be used as standards in 
subsequent screenings to allow the interpretation of new 
results as positive or negative.
Screening of the test group showed that 87% (49/56) of 
the animals experimentally infected with M. leprae had
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detectable IgM antibody to the Phen-Gl-1 antigen. Of the 7 
armadillos experimentally inoculated with M. leprae but not 
demonstrating detectable antibody, two were from resistant 
animals. Approximately 10% of the armadillos 
experimentally infected at the National Hansen's Disease 
Center are resistant to M. leprae - they do not succumb to 
lepromatous disease (95). Resistance in leprosy is 
governed by cell-mediated immunity (96) # Humoral immunity 
may not be mustered in these resistant animals. Further 
investigation is needed to determine if serological 
monitoring of armadillos may be useful in the early 
identification of resistant and susceptible animals.
Antibody profiling of armadillos experimentally 
infected with M. leprae will aid in their development as 
animal models in leprosy research (60,99)  ^ previous 
efforts to detect M. leprae antibodies in armadillos have 
exercised traditional RIA methodologies with iodinated 
fractions of the sonicated whole bacillus (6 6 ) # Those 
reports indicated that IgG antibodies to M. leprae became 
detectable only simultaneously with the appearance of AFB 
in the peripheral blood (64)# Experimentally infected 
armadillos both with and without acid-fast bacteria in the 
peripheral blood had detectable IgM antibodies to the 
Phen-Gl-1 antigen. These ELISA data suggest that IgM 
antibodies to the Phen-Gl-1 antigen are detectable well in 
advance of overt systemic infection. These antibodies 
appear to be chronically synthesized over the course of
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infection and are present in comparatively high 
concentrations until the animals are sacrificed.
Therefore, IgM class antibodies to the Phen-Gl-1 antigen 
appear to be good indicators of subclinical or early 
leprosy, and may be the more appropriate isotype for 
sero-epidemiological investigations.
Other investigators using the Phen-Gl-1 antigen in 
ELISA assays of human sera have reported approximately a 4 
to 5% apparently "false-positive" rate in presumed negative 
control groups. These reports are based on resulting ELISA 
absorbancies above 0.1 in traditional ELISA methodologies 
used on the sera of individuals from leprosy nonendemic 
areas and exhibiting no clinical signs of leprosy (23) #
Wild armadillos have been reported to harbor a 
mycobacterial infection indistinguishable from M. leprae 
(210)_ our test group contained 4/20 samples from 4 
recently captured armadillos not inoculated with M. leprae 
which yielded ELISA absorbancies statistically 
interpretable as positive. When these sera were absorbed 
with M. leprae, their ELISA reactivity was significantly 
reduced, while absorption with M. phlei and M. scrofulaceuro 
did not significantly alter their ELISA reactivity. 
Presumably, therefore, these are true positive reactions 
suggesting that modern day wild armadillos in Louisiana 
may have an M. leprae antibody prevalence rate as high as 
20%.
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In conclusion, the serology of mycobacterial diseases 
is complicated by the plethora of cross reacting antigens 
found among the various species. Isolation of an 
apparently species-specific antigen for M. leprae has 
allowed the development of serologic tests with high 
specificity. Antibody profiling of experimentally infected 
armadillos will aid their development as animal models for 
leprosy and better descriptions of M. leprae infections in 
wild armadillos, as measured serologically, may well 
provide a better understanding of the transmission of 
leprosy in humans.
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Table 3.1
Elisa-IgM v. Phen-Gl-1 quality parameters
Parameter Ratio Percent
53 (true+)
Sensitivity 53 (true+) + 6 (false-) 
16 (true-)
89
Specificity 16
53
(true-) + 0 (false+) 
(true+) + 16 (true-)
100
Efficiency 76 (N) 90
predictive 53 (true+)
of Positive 53 (true+) + 0 (false+) 100
True+ = Absorbance > 710 and known inoculation with 
M. leprae or absorbable Phen-Gl-1 antibody.
True- = Absorbance < 560 and no known history with M. 
leprae.
False+ = Absorbance > 710 with no known history with 
M. leprae and unabsorbable antibody to Phen-Gl-1
False- = Absorbance < 710 with known inoculation of 
M. leprae.
* Known resistant animals are not included.
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Table 3.2 
Legends to figures
Figure 3.1 Crossed immunoelectrophoresis of whole armadillo 
serum. A) Second dimension contains rabbit 
anti-armadillo immunoglobulins.• B) Second 
dimension contains horseradish peroxidase 
conjugated IgG fraction goat anti-human IgM (mu 
chain specific).
Figure 3.2 Optimal dilutions for ELISA. 3.2A) Absorbance 
(488 nm) resulting from nonspecific absorption 
of IgM to polyvinyl microtiter plates at various 
dilutions of armadillo serum. 3.2B) Absorbance 
(488 nm) resulting from positive pooled control 
serum reacting with various concentrations of 
Phen-Gl-I coated to wells of polyvinyl 
microtiter plates showing optimal dilution to be 
25 ug/ml. 3.2C) The difference in absorbance 
(488 nm) between control positive and negative 
antisera reacted with 25 ug Phen-Gl-I coated 
microtiter plates detected by various dilutions 
of horseradish peroxidase conjugated IgG 
fraction goat anti-human IgM (mu chain specific). 
SUBSTRATE ABS = substrate absorbance.
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Figure 3
Figure 3
Figure 3
3 Distribution of ELISA absorbance of 76 
armadillos with known experimental inoculation 
history. 4A) Frequency histogram showing number 
of samples occurring in each of 10 absorbance 
classes and demonstrating apparent bimodality. 
4B) Scatter plot of ELISA absorbances showing 
significant difference, p < 0 .0 0 1 ) in means of 
the two groups and demarcation of equivocal 
zone.
4 Regression of ELISA absorbances according to the 
presence (*) or absence (o) of acid-fast bacilli 
(AFB) in peripheral blood. * = acid-fast 
positive; o = acid-fast negative; R = resistant 
armadillos.
5 ELISA absorbance (488 nm) of 4 suspected false 
positive armadillo sera after absorption with M. 
leprae, M. scrofulaceum and M. phlei. Equivocal 
zone is demarcated by solid horizontal bars.
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Figure 3.1 
Crossed Immunoelectrophoresis of 
Armadillo Whole Serum in the First 
Dimension against (a) Anti-Armadillo 
Whole Serum; or (b) Horseradish 
Peroxidase Conjugated Anti-Human IgM 
(mu specific) in the Second Dimension.
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Chapter 4: Abstract
Using an enzyme-linked immunosorbent assay that 
detects armadillo IgM class antibodies to the apparently 
species-specific phenolic-glycolipid-1 (Phen-Gl-1) antigen 
of M. leprae, a retrospective serological survey was 
performed. Sera from 182 armadillos taken in the years 
19 60 to 1964 and predating the use of armadillos in leprosy 
research were tested. Antibodies to the Phen-Gl-1 antigen 
were detected in 17 of the sera. Absorption with whole M. 
leprae significantly reduced the antibody activity of the 
sera. Absorption with M. avium, M. intracellulare, M. 
scrofulaceum, BCG, M. dienrhoferi, M. phlei, M. rhodesiae, 
M. terrae, M. kansasii, and two new mycobacterial isolates 
from armadillos 8152 and 8480 failed to significantly alter 
the antibody activity of these sera. These antibodies 
presumably indicate that wild armadillos experienced 
infections with M. leprae as early as 1961.
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Man has traditionally been thought to be the only 
natural host of Mycobacterium leprae, the etiological agent 
of leprosy. However, studies beginning in 1968 
demonstrated that the nine-banded armadillo (Dasypus 
novemcinctus) is susceptible to experimental infection with 
M. leprae (97). since 1975, a number of reports have 
appeared which establish that wild armadillos harbor a 
mycobacterial infection indistinguishable from M. leprae 
(14,184,185,210,2ll)# Recently, five cases of human 
leprosy have been reported in individuals from Texas, whose 
only contact with M. leprae may have been through long-term 
close association with armadillos <H O )_ Thus, the 
discovery of M. leprae in the wild armadillo has not only 
raised many questions about the transmission and host range 
of leprosy, but identified a possible public health risk.
How the armadillo became infected with M. leprae is 
central to a better understanding of the transmission of 
leprosy. Generally, three possible answers have been 
proposed: a) M. leprae may be natural to the armadillo and
indigenous to the population (2 1 2 ) or armadillos may have 
acquired leprosy either by b) association with infected 
humans or c) inadvertent environmental contamination from 
experimentally infected armadillos sometime since 19 68 
(183).
We recently developed an enzyme-linked immunosorbent 
assay (ELISA) that detects armadillo IgM antibodies to the 
apparently species-specific phenolic glycolipid antigen
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(Phen-Gl-1) of M. leprae (ELISA-IgM vs. Phen-Gl-1) d 9 8 >.
We report here an evaluation of the post-19 68 environmental 
contamination hypothesis for the origin of M. leprae 
infections in wild armadillos.
MATERIALS AND METHODS
Wild armadillo sera 1960-1964; A total of 182 
armadillo serum samples were collected by Adams and Roth in 
1960-1964 as part of a survey for leptospires in wild 
animals (165,166,167)# The samples were tested for 
leptospiral antibodies and stored at -10°C for 
approximately 12 years when they were deposited in the 
Louisiana State University School of Veterinary Medicine 
serum bank and stored at -79°C. Information relative to 
sex, time, date, location of capture, known antibody titers 
and previous users was recorded for each serum.
Leptospiral serology; in 1983 the Louisiana 
Veterinary Medical Diagnostic Laboratory (LVMDL) repeated 
leptospiral antibody titration on armadillo sera that had 
been found to be positive in 19 60-19 64. The modern 
leptospiral method employed by the LVMDL uses a 
microtitration technique with commercially prepared 
antigens and control sera. The initial dilution for a 
positive sample by the LVMDL procedure was 1:100. The 
procedure originally used by Adams and Roth in 19 60-19 64 
was a tube agglutination method with individually prepared
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antigens and 1:25 as a minimum dilution for a positive 
serum.
Antigen: Native, pure phenolic-glycolipid-1
(Phen-Gl-1) was prepared by Dr. Patrick Brennan (Colorado 
State University) and obtained through contract with the 
National Institute of Allergy and Infectious Disease, Dr. 
Darrel Gwinn, Project Officer.
ELISA—IgM vs. Phen-Gl-Ii An enzyme-linked 
immunosorbent assay (ELISA) was performed according to the 
method described previously (198).
Mycobacterial species; Mycobacterial strains 8152 
and 8480 are "difficult to grow" isolates arising from the 
tissues of armadillos. They were a gift from Dr. Francoise 
Portaels (Prince Leopold Institute of Tropical Medicine, 
Antwerp, Belgium). Cultivable mycobacterial species (M. 
avium, BCG, M. diernhoferi, M. intracellulare, M. kansasii, 
M. phlei, M. rhodesiae, M. scrofulaceum, M. terrae, and 
Portaels' bacilli 8152 and 84 80 were inoculated to 
Lowenstein-Jensen (L~J) slants and grown to confluency.
The organisms were harvested using Hanks' balanced salt 
solution (HBSS) and pelleted via centrifugation at 700 x g. 
They were subsequently washed 5 times with HBSS and 
enumerated (182)  ^ Bacterial suspensions were diluted to 
contain 1 X 109 organisms per ml in 0.067 M phosphate 
buffered saline (PBS) with 1% bovine serum albumin 
(PBS/BSA), pH 7.2. M. leprae were propagated in
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armadillos, harvested as described previously (215) an(j 
likewise diluted in PBS/BSA.
Absorption of sera; Enumerated bacterial 
suspensions were aliquoted to disposable microfuge tubes 
(Beckman Instruments, Palo Alto, CA) in 200 .pi volumes at a 
concentration of 1 x 10^ organisms/ml. Serum samples with 
ELISA absorbances interpretable as positive were diluted 
1:180 in PBS/BSA and added in 200 pi volumes to tubes 
containing mycobacteria or PBS/BSA alone. Sera and 
bacteria were mixed by gentle shaking every 15 min as the 
tubes were incubated for 1 hr at 37°C. The tubes were then 
held overnight at 4°C, and the suspensions were clarified 
by centrifugation on a Beckman Microfuge model B for 5 min 
before use. The absorbed serum was assayed in the ELISA as 
described above.
RESULTS
Wild armadillo serum 1960-1964
History: Armadillo serum samples collected in
1960-1964 originated from a six-parish area of the 
Atchafalaya Basin in south central Louisiana. The area is 
located, west of the Mississippi River and north 
approximately 40 miles from both the Gulf South Research 
Institute in New Iberia, Louisiana, and the National 
Hansen’s Disease Center in Carville, Louisiana. The Basin 
is a wild swamp area with mixed habitat and hosts abundant 
wildlife. It is similar in habitat but different in 
location to the site of the original report of M. leprae in
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wild armadillos by Walsh, et al. (210) ^ Atchafalaya
holds soils common to the Louisiana delta region with pH 
ranging from mildly acidic (5.0) to slightly alkaline (7.7) 
(188). rphe Specific capture site of each armadillo could 
be identified within 100 yards and the collection area is 
mapped in Figure 4.1. Histological sections of kidneys 
from 50 of these armadillos were examined in 1973 by 
Stewart and Crowell (195). Acid-fast bacilli were not 
observed in the tissues examined. Liver tissues were not 
examined.
Utility of pre-susceptible sera after 20 years of 
storage; Armadillo sera taken in 1960-19 64 were 
evaluated for usability after 20 years of storage. 
Leptospiral serology was repeated on the 11 known positive 
samples. The modern leptospiral technique employs a 
microtitration method with commercially prepared antigens 
and standardized antisera. The technique of 20 years ago 
utilized tube agglutination with individually prepared 
antigens. Initial dilutions of the two techniques also 
differ and, therefore, direct correlation of titer results 
between the two methodologies is not possible. However, 
positive and negative correlations are still feasible. As 
shown in Table 4.1, 7 of the 11 armadillo sera known to be 
positive for Leptospira species retained their antibody 
activity after 20 years of storage. None of the tested 
sera changed in antibody specificity to the individual 
leptospiral antigens, a proportion (4/11) of the sera lost
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all detectable antibody activity over the 20 years of 
storage.
ELISA; The 182 wild serum samples taken 4-8 
years before initial susceptibility studies of armadillos 
to M. leprae were performed in 1968, were screened in the 
ELISA IgM vs. Phen-Gl-1. The absorbances of these samples 
were inspected in a frequency histogram which displayed a 
positive skew (Figure 4.2). Resulting absorbances were 
judged according to the definitions of positive and 
negative as previously determined (198)  ^ an(j 17 samples 
exhibiting absorbance readings above 0.720 were classed as 
presumptive positive.
Absorption of antibody activity: The 17 presumed
positive sera were absorbed with whole M. leprae and 11 
other heterologous mycobacterial species. The ELISA was 
repeated and the absorbance results were analyzed by paired 
t-test for significance. As shown in Figure 4.3, as a 
group the 17 sera were significantly (p < 0.001) depleted 
of detectable antibody reactive with Phen-Gl-1 after 
absorption with whole M. leprae. As a group the ELISA 
absorbances were not significantly altered when absorption 
was performed with other mycobacterial species. ELISA 
absorbances of a highly positive control (+) serum derived 
from an armadillo experimentally infected with M. leprae 
followed an identical pattern. Absorbances of a negative 
control (-) serum remained unchanged.
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DISCUSSION
The discovery of M. leprae in the wild armadillo 
created controversy concerning the origin, transmission and 
host range of leprosy. Whether M. leprae is indigenous to 
armadillos, or wild armadillos acquired M. leprae either 
by association with infected humans or contact with M. 
leprae contaminated materials some time since the 19 68 
armadillo susceptibility trials, has been widely 
debated (183). evaluated the 1968 environmental
contamination hypothesis by means of a retrospective 
serological survey. The sera from 182 wild armadillos 
taken in years (19 60-64) pre-dating the 19 68 susceptibility 
trials were examined for IgM antibodies to the Phen-Gl-1 
antigen of M. leprae.
Antibody to the apparently species-specific phenolic 
glycolipid antigen (Phen-Gl-1) of M. leprae (22,33,78) was 
detected in 17 of 182 sera taken from wild armadillos in 
1960-64. Reactivity of these antibodies was significantly 
reduced by absorption with whole M. leprae. This 
reactivity was not significantly altered by absorption with 
11 other mycobacterial species tested (Fig. 4.3). The 
absorption scheme sought to eliminate antibodies that might 
have been induced by some "Original Mycobacterial Sin" (4). 
Members of the MAIS antigenic complex (12) (m . avium, M. 
intracellulare, M. scrofulaceum) and BCG may potentiate the 
immunologic response to M. leprae ( H) and may hold common 
antigens (137). Additionally, common soil mycobacteria,
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represented here by M. diernhoferi, M. phlei, M. rhodesiae, 
and M. terrae, may also induce this phenomenon. M. 
kansasii is known to share a common phthicerol core antigen 
with M. leprae (81) an<j other, as yet unrecognized, 
mycobacterial species (represented here by Portaels1 
bacilli 8152 and 8480 isolated from armadillo tissue) could 
also function in this area. Failure by these species to 
absorb the antibody activity to the apparently 
species-specific Phen-Gl-1 antigen suggests that those 
antibodies were elicited as a result of exposure to M. 
leprae.
Long-term storage of serum samples may result in 
protein deliquescence, antibody aggregation, or loss of 
antibody reactivity (185)^ rp0 assure the utility of these 
182 sera after 20 years of storage, leptospiral antibody 
activity was reassessed. Since technical methodologies of 
leptospiral serology have changed in 20 years, direct 
correlation of titer results was not possible. Results 
could only be judged as positive or negative. A proportion 
(4/11) of these sera apparently had lost leptospiral 
antibody activity over the years of storage (Table 4.1). 
Since the true proportion of sera that had lost reactivity 
could not be discerned, it was not possible to describe 
prevalence rates in the 19 60-19 64 population. However, 
none of the serum samples previously negative for 
Leptospira species antibodies was found to be positive 
after 20 years of storage. These sera maintained their
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specificity and had utility for seroepidemiological 
investigation.
Adams and Roth collected these sera along with 
visceral tissues from 182 armadillos in the Atchafalaya 
Basin of south central Louisiana during the years 1960-1964. 
Samples were collected as part of a survey for leptospires 
in Louisiana wildlife. After testing, the materials were 
stored frozen for future reference. In 1973, Stewart and . 
Crowell (195) examined sections of kidneys from 50 of these 
armadillos but failed to detect acid-fast bacteria. 
Armadillos experimentally infected with M. leprae at the 
National Hansen's Disease Center rarely express acid-fast 
bacteria in renal tissues (173)r ana the failure of Crowell 
and Stewart to detect acid-fast bacteria in these kidney 
tissues should not be considered unusual.
Certain environmental associations have been made with 
leprosy infections in humans, and there appear to be trends 
to higher prevalence rates in humid climates (80)# Kazda 
recently reported isolation of a leprosy-like organism from 
a peat bog in Norway having a pH of 5.5 (92)  ^ Such mildly 
acidic soil pH conditions have been identified as optimal 
for isolation of some mycobacterial species from soils 
(10,190)a The Atchafalaya Basin is a wild swamp area and 
soils of the region are typical to the delta of Louisiana, 
ranging in pH from 5.0 to 7.7 depending upon drainage. No 
reports have been made of attempts to isolate M. leprae or
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leprosy-like organisms from soils of the Atchafalaya, but 
such investigations may be warranted.
Antibodies may be regarded as highly specific 
indicators of infectious experiences. The presence of 
antibodies to the apparently species-specific Phen-Gl-1 
antigen in armadillos during the years 1960-19 64 suggests 
that M. leprae was present in the wild population before 
the armadillo was used as an experimental host for M. 
leprae cultivation. Presumably then, the original 
infection of wild armadillos with M. leprae could not have 
resulted from any inadvertent environmental contamination 
associable with the 19 68 armadillo susceptibility trials or 
any subsequent experimentation with armadillos. The true 
origin of M. leprae infection in the wild armadillo 
remains an important scientific question. If the infection 
was not the result of accidental contamination, how have 
armadillos contracted leprosy? An understanding of the 
origin of this infection in armadillos may have 
considerable impact on our understanding of the 
transmission of leprosy in humans.
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Table 4.1
Reassessment of 19 60-19 64 wild armadillo 
leptospiral serology after 20 years of storage
Sample Canicola Grippota Pomona Icteroh*5
pre now pre now pre now pre now
9 * . 400 400 • *
14 100 • • * •
19c • • • 100 •
34 • 100 • 100 •
36 • 100 400 • •
96 400 • • 100 •
10 6d ■ • • 25 200 100 *
118 * 100 ■ • « 100 200
165d * « ■ 25 100 • •
208 • . 100 100 • * • •
209d ■ m 100 100 25 100 25 100
a=Grippotyphosa
b=Icterohemorrhagea
Four culture positive when captured
c L. pomona 
d L. autumnalis
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Figure 4
Figure 4
Figure 4
Table 4.2 
Legends to figures
1 Map of general capture area where 182 wild 
armadillos were taken by Adams and Roth in the 
years 19 60 to 19 64.
2 ELISA absorbances of 182 wild armadillos taken 
in the years 19 60 to 19 64 plotted in a frequency 
histogram of equal class intervals. Figure 
demonstrates positive skew of sample group.
3 ELISA absorbances of presumed positive wild 
armadillo sera collected in the years 19 60 to 
19 64 and absorbed with various mycobacterial 
species. Absorption with whole M. leprae 
resulted in significant (paired-t; p < 0 .0 0 1 ) 
reduction in ELISA absorbances. Absorption with 
other mycobacterial species not significant. 
Point(+) = control positive serum; point(-) = 
control negative serum; point 1-17 = serum 
samples from 1960-19 64 wild armadillos.
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Chapter 5, Abstract:
Sera from 216 wild armadillos of two parishes in 
south central Louisiana and Florida were tested by ELISA 
for IgM antibodies to the phenolic-glycolipid-1 antigen of 
M. leprae. Antibodies were not detected in sera from 
Florida armadillos (0/30). Louisiana armadillos had an 
antibody prevalence rate averaging 12.5% (23/186).
Antibody prevalence rates between Louisiana and Florida 
were significantly different. Antibody prevalence rates of 
armadillos of the two Louisiana parishes were similar. The 
clinical disease rate was estimated to be 2.7% for 
Louisiana armadillos by histologic examination to detect 
disseminated acid-fast bacteria. The population 
characteristics and environmental conditions of the 
Louisiana leprosy positive habitat were described. Future 
comparisons of prevalence rates in armadillos of different 
habitats will aid in understanding the transmission of 
leprosy and further develop the armadillo as an animal 
model for leprosy research.
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The transmission of leprosy is not yet understood. It 
is suspected to be obligately transmitted from man to man 
and may require long term close contact with infected 
humans (58). However, other mechanisms have been 
implicated. Environmental conditions have been described 
that correlate with increased prevalence rates of 
leprosy (80) and Kazda has reported isolation of an 
M. leprae-like organism from a sphagnum bog in Norway (92), 
Mycobacteria sharing certain phenotypes with M. leprae may 
be found in nature. The role of environment or 
environmental microorganisms as pathogens or additional 
factors influencing the transmission of leprosy has not 
been determined (190,191), ^ better understanding of these
influences may aid in the control of leprosy.
Epidemiologic studies on the transmission of leprosy 
in man are complicated by low susceptibility and mobility 
of the human population. However, leprosy is zoonotic in 
the nine-banded armadillo (Dasypus novemcinctus)
(14,185,186,210 ,2 1 1 ) f an(j approximately 90% of armadillos 
are susceptible to leprosy (95,96), Thus armadillos may be 
used as an animal model to study the transmission of 
leprosy.
To effectively use the armadillo as an animal model, 
large groups must be sampled with sensitive screening 
techniques and relevance must be given to the environment 
and population characteristics of the groups studied. 
Previous investigations of leprosy in wild armadillos have
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relied on histologic examinations to detect disseminated 
acid-fast bacteria. The leprosy-like disease has been 
confirmed in various locales and prevalence rates have been 
estimated to range from 0 to 25% (14,185,186,210,211)^
Such disparate estimates may be the result of insensitivity 
of the histologic screen, population characteristics or 
environmental conditions.
We recently developed an enzyme-linked immunosorbent 
assay (ELISA) that detects armadillo IgM antibodies to the 
phenolic-glycolipid-1 (Phen-Gl-1) antigen of M. leprae 
(198)# This antigen is chemically defined and apparently 
species specific for M. leprae (22,33,78)_ Antibodies to 
this antigen may be detected in the absence of 
disseminated disease (198)_ ^e report here preliminary 
data assessing IgM anti-Phen-Gl-1 antibody prevalence rates 
in wild armadillos of Louisiana and Florida, and a 
description of a leprosy positive armadillo habitat.
MATERIALS AND METHODS
Serum and histologic samples; Armadillos were 
captured in 2 parishes of south central Louisiana:
Iberville and Point Coupee. A total of 131 armadillos from 
Iberville parish were taken by local trappers in the 
vicinity of Sunshine, Louisiana and brought to the National 
Hansen's Disease Center (NHDC) in Carville, Louisiana. At 
the NHDC armadillos were sampled by venipuncture and snips
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of ears were taken for histologic examination to detect 
acid-fast bacilli (AFB). A total of 55 different armadillos 
in Point Coupee parish were sampled in the field near Krotz 
Springs, Louisiana and along a tract where 2 armadillos 
sero-positive for leprosy had been taken in the years 
1960-64 (see preceding chapter). Field serologic samples 
were taken in capillary tubes after the excision of a 
toenail. A sample of ear was taken before the animals were 
released.
Serum samples from 30 Florida armadillos were 
collected by Dr. E. Storrs (Florida Institute of 
Technology) and provided as a gift through the National 
Institute of Allergy and Infectious Diseases (Dr. Darrel 
Gwinn, Program Officer).
Population Density; Armadillos in Point Coupee 
Parish were captured over a 10 mile stretch of levee 
bordering the Atchafalaya River and comprising an area of 
approximately 200 ha (500 acres). Using a system of 
capture-mark-recapture the total population was estimated 
by the Lincoln-Peterson method: [(total number of marked 
and unmarked animals taken on the final trapping day) X 
(total number of animals marked)] / (total number of 
previously marked animals recaptured on the final trapping 
day) (108) ^ Tjie population density was the ratio of total 
population/area sampled.
Antigen: Native purified phenolic-glycolipid-1
(Phen-Gl-1) was prepared by Dr. Patrick Brennan (Colorado
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State University) and obtained through contract with the 
National Institute of Allergy and Infectious Diseases (Dr. 
Darrel Gwinn, Project Officer).
ELISA; Enzyme-linked immunosorbent assay (ELISA) 
was performed according to the method described 
previously (198).
Histology: Tissue was prepared by standard
methods as reported previously and examined for the 
presence of acid-fast bacteria (AFB) in nerves (8 6 ) #
RESULTS
Capture area; Armadillos were taken from 2 
parishes in Louisiana: Iberville and point Coupee. The 
parishes border, but specific capture areas were some 40 
miles apart. The Point Coupee site was a tract along the 
Atchafalaya River while Iberville bordered the Mississippi 
River. Both parishes provided excellent habitat and hold 
abundant wildlife. A total of 49 animals were marked in the 
Point Coupee area and 1 was recaptured on the final 
trapping day. Using the Lincoln-Peterson method of 
capture-recapture (108) the population density in Point 
Coupee was estimated to be 5 per 7 acres. The density in 
Iberville was not calculated. Average climatic conditions 
of the 2 parishes were also similar (Table 5.1): annual 
rainfall 54.9", relative humidity 73.7%, yearly temperature 
69°F. Neither of the parishes had been inundated by floods
86
since 1973 (35) ^ areas where armadillos were taken were
poorly drained. Soils of the two areas were only slightly 
different with Convent types (coarse-silty, mixed, thermic 
aerie fluvaquents, pH 5.6 to 8.4) predominating Point 
Coupee; and Commerce types (fine-silty, mixed, thermic 
aerie fluvaquents, pH 5.6 to 7.8) predominating Iberville 
(186,187)# conditions occupied by Florida armadillos
were unknown.
Antibody prevalence: A total of 186 serum samples
taken from armadillos in Louisiana (131 Iberville, 55 Point 
Coupee) and 30 samples from Florida armadillos were 
screened by ELISA for IgM antibodies to Phen-Gl-1. The 
resulting absorbances were judged according to definitions 
of positive and negative as previously determined for the 
ELISA (198) (Fig. 5.1). A total of 23 (12.5%) Louisiana 
armadillos had detectable IgM antibodies to Phen-Gl-1. 
Antibodies were detected in 10.7% (14/131) of the 
armadillos from Iberville parish and 16.3% (9/55) of 
the armadillos from Point Coupee. None of the Florida 
armadillo sera had detectable IgM antibodies to Phen-Gl-1. 
Antibody prevalence rates from the various groups were 
compared for significant differences by Chi square (Table
5.2). Armadillos from Iberville and Point Coupee were not 
significantly different. However, antibody prevalence rates 
of Louisiana and Florida armadillos were significantly 
different (p < 0.05).
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Histologic prevalence: Leprosy prevalence rates
for Louisiana armadillos were also described by histologic 
methods. Acid-fast bacteria (AFB) were detected in 2.7% 
(5/186) of the Louisiana animals. Armadillos from both 
parishes presented with detectable AFB in ear tissues: 3 
Iberville, 2 Point Coupee. Each armadillo with detectable 
AFB also had positive serologic findings. However, 18 
armadillos from both parishes had detectable IgM antibodies 
to Phen-Gl-1 without manifesting detectable AFB.
DISCUSSION
To effectively use the armadillo as an animal model 
for the transmission of leprosy; large populations must be 
sampled with sensitive screening methods and relevance must 
be given to population characteristics and environment of 
the groups under study, previous studies of leprosy in the 
wild armadillo have relied on histologic methods to 
identify infected animals. Histology alone may lack 
adequate sensitivity to describe leprosy prevalence rates 
in armadillos. Acid-fast bacteria may only be detected in 
armadillos once infection has established and disseminated. 
Therefore histology is a measure of clinical disease. 
Examination of ear tissues from Louisiana armadillos 
indicated clinical leprosy in only 2.7% (5/186) of the 
animals examined. Previous reports using histology to 
describe the prevalence of leprosy in Louisiana armadillos
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have also averaged only 4.9% (116), However, the ELISA 
suggest armadillos may have a greater experience with 
leprosy, prevalence rates for IgM antibodies to Phen-Gl-1 
averaged 12.5% in Louisiana armadillos. This lipid antigen 
promotes a predominate long term IgM response (24,198,217), 
Antibodies may be elicited after exposure to antigen or 
early in the course of infection. Thus, the ELISA is a 
better reflection of sub-clinical and antigenic 
experiences. Used in combination, these methods should 
provide adequate sensitivity to investigate leprosy in the 
wild armadillo.
The population characteristics operated by different 
groups of armadillos may influence their observable 
prevalence rates. If leprosy is obligately transmitted from 
armadillo to armadillo, then groups with greater density 
might have higher prevalence rates, those with lower 
density, lower rates. Armadillos along a research site in 
the Atchafalaya Basin of Point Coupee Parish were estimated 
to have a density of 5 per 7 acres with an antibody 
prevalence rate of 16.3%. In 1952, the only previous 
estimate of density for armadillos in another part of 
Louisiana was 1 per 7 acres (48), Future comparisons of 
antibody prevalence rates in other groups will also require 
new calculations of population density to better understand 
the transmission of leprosy.
If environmental factors influence transmission then 
armadillos in different environments may have different
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prevalence rates of leprosy. The two groups of Louisiana 
armadillos inhabited similar environments. Antibody 
prevalence rates of the two groups also were similar. 
Environmental conditions of high relative humidity and warm 
vegetation temperatures were implicated to influence 
increased historical human leprosy prevalence rates in 
Norway (80) # Louisiana armadillos had significantly higher 
antibody prevalence rates than Florida armadillos. 
Antibodies to Phen-Gl-1 were not detected in Florida 
armadillos. Naturally acquired leprosy has not been 
reported in the Florida armadillo. Louisiana and Florida 
armadillos appear to be equally susceptible to experimental 
infection with M. leprae (93). but, the populations may 
occupy different environments and until recently may not 
have been in contact. Armadillos in Louisiana slowly 
migrated here from Texas and Mexico. Armadillos may have 
been accidentally introduced to Florida in 1925 following 
the escape of several pairs from a private zoo in.Cocoa. 
Zoologists report that over the years these 2 populations 
have eventually merged (48,75,111) f an(j except for leprosy, 
there are no discernible differences between the groups.
The actual reason for these observed differences in 
antibody prevalence rates between Louisiana and Florida 
armadillos is uncertain but may be due to differences in 
population characteristics, environment or availability 
ofcontact with an infectious source.
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In conclusion, leprosy is zoonotic in wild armadillos 
and these animals may be used to study the transmission of 
leprosy. Serologic screening combined with histology 
should provide suitable sensitivity for these 
investigations. While for the most part armadillos are 
susceptible to leprosy, significant differences in 
prevalence rates have been observed. These differences may 
be due to environmental factors, population characteristics 
or availability of contact with an infectious source.
Future comparisons of leprosy prevalence rates from 
armadillos in different environments and/or operating 
different population characteristics will help decipher the 
transmission of leprosy in armadillos and aid our 
understanding of the transmission of leprosy in man.
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Table 5.1 
Climatologic Summary 1951 to 19 80 
South Central Louisiana*
Month Relative humidity 
am % pm
Rainfall
inches
Rain days Temp
O p
Jan. 85 65 4.58 9 51.7
Feb. 54 59 4.97 9 54.2
Mar. 85 57 4.59 9 60.8
April 88 56 5.59 7 68.2
May 90 57 4.82 8 74.8
June 91 58 3.11 9 80.3
July 91 62 7.07 13 82.1
August 92 62 5.05 12 81.7
Sept. 91 61 4.42 9 78.4
Oct. 88 54 2.63 5 69.1
Nov. 88 58 3.95 7 60.0
Dec. 86 63 4.99 10 54.0
average
Total
month 73.79 4.22
50.72
8.9
107
67.9
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Table 5.2
Chi Square Comparison of Phen-Gl-1 Antibody 
Prevalence Hates of Louisiana and Florida 
Armadillos
Number Iberville Point Louisiana Florida
 _________________  Coupee____________________________
Negative 113 46 163* 30
Positive 13 9 23 0
Percent
Positive 10.3 16.3 12.5 0
Iberville v. Point Coupee x2=1.31 (not significant) 
Louisiana v. Florida x2=4.15 (p<0.05)
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Table 5.3 
Legend to figure
Figure 5.1. Scattergram of ELISA absorbances for IgM
antibodies to Phen-Gl-1. Absorbance coded X 
1000. Horizontal bars mark equivocal zone 
previously determined for the ELISA.
Absorbances above 710 on graph are positive for 
IgM antibodies, below 580 negative. Point 
Coupee (Louisiana) N=55, Iberville (Louisiana) 
N=131, Florida N=30, (Louisiana N=186).
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Chapter 6 , Abstract:
An enzyme-linked immunosorbent assay (ELISA) that 
detects IgM antibodies to the apparently species specific 
phenolic-glycolipid-1 antigen of M. leprae was evaluated 
for its efficacy as a management tool in the in vivo 
propagation of M. leprae in armadillos. Screening 
armadillos both pre and post experimental infection 
indicated that IgM antibodies became detectable on average 
after 186 days and remained so over the course of infection. 
ELISA absorbances from sera taken at sacrifice showed good 
correlation with the liver yield of M. leprae. An ELISA 
absorbance of greater or less than 1.2 at sacrifice could 
be used to predict satisfaction with the harvest 97% of the 
time. ELISA profiles of resistant armadillos showed that 
IgM antibody production was irregular or absent, and the 
ELISA could be used to predict resistance in armadillos 
both early and late in experimental infections. The ELISA 
successfully identified armadillos with naturally acquired 
leprosy and indicated that these armadillos may also have 
unusual antibody profiles that would make them unsuitable 
for controlled immunologic studies. IgM antibodies were 
detectable earlier and more reliably than previously used 
histologic monitoring measures. The ELISA is less labor 
intensive and non-invasive, making it a useful tool in the 
management of experimental leprosy infections in 
armadillos.
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Mycobacterium leprae has not been cultured on 
artificial media and investigators must rely on _in vivo 
propagation as a source of bacilli. The nine-banded 
armadillo, Dasypus novemcinctus, is well developed as a 
host for propagation of M. leprae, and studies have begun 
that would use this animal as a model for the pathogenesis 
of leprosy (86,93,94,97,194)_ Effective use of animals in 
research on infectious diseases requires monitoring of the 
host over the course of experimental infection. Previous 
methods to monitor experimental infections of M. leprae in 
armadillos have commonly relied on histologic techniques 
(97). These techniques are labor intensive and invasive to 
the animal. Serologic assays are less laborious and offer 
hope for greater efficiency in management of experimental 
infections, previous serologic attempts to monitor M. 
leprae antibodies in armadillos have relied on traditional 
Staphylococcal-A radioimmunoassay methodologies with 
iodinated fractions of the sonicated whole leprosy bacillus. 
Using undefined antigen mixtures these assays lacked 
specificity and only detected M. leprae antibodies 
simultaneous with the appearance of a disseminated 
infection (151,160)_ We recently developed an enzyme 
linked immunosorbent assay (ELISA) that detects armadillo 
IgM antibodies to the chemically defined and apparently 
species-specific phenolic-glycolipid-1 (Phen-Gl-1) antigen 
of M. leprae (198). we report here an evaluation of this
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ELISA for applications in the management and investigation 
of experimental M. leprae infections in armadillos.
MATERIALS AND METHODS
Serologic and Histologic Samples; Armadillos at 
the National Hansen's Disease Center are captured from the 
wild and housed for the production of M. leprae. They are 
bled approximately every 90 days, both pre and post 
experimental inoculation to examine for the presence of 
acid-fast bacilli (AFB) in peripheral blood. Histologic 
samples of ear tissues are also taken and examined for AFB 
to monitor dissemination of disease. Plasma from these 
bleedings is separated and stored frozen for future 
reference. A total of 457 such plasma samples from 210 
different armadillos were used in this study. Armadillos 
were at varying stages of infection with an average 
intravenous inoculum of 5 X 10® M. leprae derived from 
human leproma and armadillo passage. Infection status 
ranged from not yet inoculated to sacrificed. Status and 
clinical history, according to the date of each serum 
sample, were recorded as part of the routine production of 
M. leprae.
Antigen: Native purified phenolic glycolipid-1
(Phen-Gl-1) was prepared by Dr. Patrick Brennan (Colorado 
State University) and obtained through contract with the
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National Institute of Allergy and Infectious Diseases (Dr. 
Darrel Gwinn, Project Officer).
ELISA; Enzyme-linked immunosorbent assay (ELISA) 
was performed according to the method previously 
described (198)<
Histology; Histologic evaluations were performed 
using standard methods described previously (215)^
RESULTS
Comparison of ELISA with yield of M. leprae;
The ELISA absorbancies of sera from 35 armadillos 
sacrificed after experimental infection with an average 
intravenous inoculum of 5 x 10® M. leprae were compared to 
their liver yield of AFB. Armadillo harvests yielding less 
than 1 x 1 0 ? organisms per gram of liver tissue are 
considered unsatisfactory for production purposes (203)_
In this comparison, all armadillos with unsatisfactory 
harvests were defined to yield 1 x 1 0  ^ organisms per gram 
of liver tissue. Actual yields from these armadillos may 
have been less. Armadillos yielding greater than 1 X 10? 
organisms per gram of liver tissue were compared using the 
log of their actual yield. As shown in Figure 6.1, there 
is a significant correlation between ELISA absorbance and 
the yield of M. leprae from liver tissues at sacrifice 
(r = 0.7261) (p <0.001). The majority (25/26) of 
armadillos yielding satisfactory harvests (greater than 1 x
100
107 M. leprae per gram of liver tissue) had ELISA 
absorbances greater than 1.2 at sacrifice. None of the 
armadillos with unsatisfactory harvests (1 X 107 or less M. 
leprae per gram of liver tissue) had ELISA absorbances 
greater than 1.2 at sacrifice. Using the criteria of ELISA 
absorbances greater or less than 1.2 the satisfaction with 
M. leprae yield at sacrifice was predictable 97% (34/35) of 
the time.
ELISA profile of resistant armadillos:
Serial samples from four armadillos subsequently shown 
to be resistant to experimental infection with M. leprae 
were screened by the ELISA-IgM v. Phen-Gl-1 (198). As 
shown in Figure 6.2, the resulting ELISA absorbances were 
compared with their days post-infection. Two armadillos 
failed to produce detectable IgM antibody to the Phen-Gl-1 
antigen in any of the samples tested. IgM antibody to the 
Phen-Gl-1 antigen was detectable in a third armadillo at 
246 days post-infection; but that antibody waned after 452 
days. A fourth armadillo also showed an irregular pattern 
of IgM antibody response to the Phen-Gl-1 antigen. Acid- 
fast bacteria were not detected by histologic examination 
of ear tissues from these 4 armadillos.
ELISA profile of armadillos with wild-type 
infection:
Armadillos not experimentally infected with M. leprae 
but obtained from the wild with ELISA absorbances greater 
than 0.71 are interpretable as positive in the ELISA-IgM v.
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Phen-Gl-1 Presumably these animals have acquired
leprosy naturally in the wild (210), Retrospective samples 
were available for 8 such armadillos in this study (Fig.
6.3). Their ELISA absorbances before experimental 
infection ranged from 0.743 to 1.155. In one animal (1) 
a disseminated acid-fast bacterial infection was found 
prior to experimental infection with M. leprae by 
histologic examination of ear tissues. This armadillo was 
removed from the colony. The ELISA absorbances of this 
animal increased until the time of removal. A second (3) 
animal also developed detectable AFB in ear tissues within 
26 days of experimental infection with M. leprae. ELISA 
absorbances showed a slight but steady increase until this 
animal was also removed from the colony. Three other 
armadillos (2,4,5) had a steady and progressive increase in 
ELISA absorbances after experimental inoculation with M. 
leprae. One (2) developed signs of a disseminated 
infection as early as 97 days post inoculation. The two 
other armadillos (4,5) did not express detectable AFB in 
ear tissues over the time these samples were taken. Three 
other armadillos (6,7,8) presenting from the wild with . 
ELISA absorbances interpretable as positive showed a 
different pattern of ELISA absorbances after inoculation 
with M. leprae. Absorbances declined such that IgM 
anti-Phen-Gl-1 antibodies were not detectable.
Disseminated AFB were detected in ear tissues of one animal 
(8 ) at 97 days and it was removed. ELISA absorbances of
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the other 2 animals (6,7) eventually increased again to 
detectable levels, and in one (7) AFB were detected in the 
blood at 404 days.
Kinetics of antibody development;
A total of 404 serum samples from 19 8 armadillos at 
various stages of infection were tested by ELISA to 
determine the time course of development of IgM antibodies 
to the Phen-Gl-1 antigen. Armadillos presenting from the 
wild with postive ELISA were not included. Sera from 
sacrificed armadillos with unsatisfactory yields were also 
not included. The actual wild experience, as well as the 
eventual possibility of resistance for all armadillos, 
could not be determined; and some wild infected and 
resistant armadillos are no doubt included in this group of 
198. The mean ELISA absorbances were calculated as a mean 
of each group of sera taken in 82 day intervals post 
infection. Means were plotted according to the last day in 
that interval (Fig. 6.4). Using the statistical 
definitions previously derived for interpreting positive 
and negative in this ELISA (198), the average day an 
armadillo might be expected to elicit detectable IgM 
antibodies to the phenolic-glycolipid-1 was approximately 
200 days post experimental infection. After rising to 
detectable levels, IgM production appears to continue over 
the course of infection. Average times for antibody 
detection were also estimated mathematically in a 
Litchfield-Wilcoxon test (H2) (Table 6.1). This method
103
estimated that 50% of the armadillos would have detectable 
IgM antibody to Phen-Gl-1 by 186 days post infection with 
M. leprae. The 95% confidence interval on this 50% day 
found its boundaries at 150 and 230 days post infection.
At 76 days post infection 16% of the animals probably have 
detectable antibody and at 455 days post infection at least 
84% of the armadillos should be positive by the ELISA. In 
comparison, the average (arithmetic mean) day armadillos 
might exhibit a disseminated acid-fast bacterial infection 
as detectable by histologic examination of ear tissues was 
found to be 519 days post infection. The confidence 
interval on this average histologic positive day exceeded 
the boundaries of the plot. Additionally, data from 70 
armadillos was sufficient to allow comparison of the ELISA 
with histologic methods for early identification of 
positive animals. Using those same 82 day intervals, a 
positive ELISA preceded a positive histologic examination 
by at least 82 days 92% (65/70) of the time. ELISA and 
histology tied 4% (3/70) of the time, and histology was 
positive before ELISA 2.8% (2/70) of the time.
DISCUSSION
The nine-banded armadillo, Dasypus novemcinctus, is 
well developed as a host for the in vivo propagation of 
M. leprae (94,97)p Following experimental infection, the 
armadillo liver commonly yields 10^ harvestable M. leprae
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per gram of tissue. Unfortunately, not all armadillos 
succumb to a lepromatous infection and approximately 1 0% of 
the animals are resistant to M. leprae (95,96,172) Early 
identification of resistant armadillos would allow their 
removal from production and aid in identifying animals with 
unsuitable immunologic characteristics for other studies. 
These data indicate that the ELISA-IgM v. Phen-Gl-1 is an 
effective method for monitoring armadillos experimentally 
infected with M. leprae. Serologic monitoring is less 
labor intensive and may be used effectively earlier in the 
course of experimental infection by M. leprae than 
histologic methods previously applied.
Histologic examination of ear clip tissues and 
microscopic examination of buffy coat blood smears for 
acid-fast bacilli are the only previous objective methods 
to monitor experimental infections of M. leprae in 
armadillos (97,215)  ^ Histologic methods are more laborious 
than serologic methods and require greater skill and 
training. When acid-fast bacilli are detected by 
histologic methods, they indicate a disseminated M. leprae 
infection. Unfortunately, not all armadillos that succumb 
to M. leprae evidence a disseminated infection in ear 
tissues or blood smears. However, apparently all 
armadillos that succumb to M. leprae produce detectable IgM 
antibodies to the Phen-Gl-1 antigen and 9 6% (28/29) have 
ELISA absorbances greater than 1.20. The average time for 
histologic methods to indicate a successful disseminated
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infection was 519 days. The average time for the ELISA to 
detect antibodies was 186 days post-infection. The ELISA 
preceded or tied a positive histologic finding by at least 
82 days 97% (68/70) of the time. Therefore, in the course 
of an experimental infection with M. leprae, ELISA 
monitoring for IgM antibodies to the Phen-Gl-1 antigen 
appears to be more predictive, less labor intensive, and an 
earlier objective monitoring method than currently used 
histologic means.
Resistance to leprosy is governed by cell mediated 
immunity (86,94)# Limited'observations of resistant 
armadillos suggest their IgM antibody production to 
Phen-Gl-1 is irregular or absent. In successful infections 
this antibody production appears to be continuous and 
results in high ELISA absorbances at sacrifice. After 455 
days, at least 84% of all armadillos should develop 
detectable IgM antibodies to the Phen-Gl-1 antigen. 
Therefore, monitoring armadillos by ELISA may prove useful 
in predicting resistance to M. leprae early in the course 
of experimental infections in armadillos.
Armadillos are known to harbor a naturally acquired 
mycobacterial infection that is indistinguishable from M. 
leprae (14,184,185,210,211)# por the armadillo to be used 
effectively as an animal model in leprosy research or in 
the in^  vivo propagation of M. leprae, care must be taken to 
avoid animals experienced with leprosy in the wild. 
Armadillos presenting from the wild with detectable
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antibodies to Phen-Gl-1 often responded differently from 
other animals to experimental infection. Early 
dissemination and progressive rise in antibodies suggests 
exacerbation of pre-existing infections. A drop in 
antibody may reflect an unusual immune potential.
Therefore, pre-screening armadillos by ELISA might be 
helpful in avoiding wild-type contamination of culture 
strains and aid researchers in selecting animals 
appropriate for study.
The ELISA-IgM v. Phen-Gl-1 appears to have good 
application as an aid in the management of experimental 
infections with M. leprae in armadillos. The assay can 
assist in identifying satisfactory harvest times, resistant 
animals, and those that experienced leprosy in the wild. 
Like humans armadillos appear to be somewhat heterogenous 
in their immunologic responses to M. leprae, but on average 
appear to develop detectable IgM antibodies to the 
Phen-Gl-1 antigen approximately 6 months after experimental 
intravenous inoculum of 5 x 108 organisms. This lag in IgM 
antibody response is a curious event and may relate to the 
size of inoculum or the lipid nature of this antigen.
Future studies with this antigen will better refine this 
ELISA as an aid for the in vivo propagation of M. leprae 
and may lead to a better understanding of the immune 
response in leprosy.
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Table 6.1
LITCHFIELD-WILCOXON
To determine mean time of IgM antibody positive
Days positive/negative percent positive.
82 3 / 1 4 21 %
164 18 / 51 35 %
246 19 / 34 55 %
328 20 / 26 76 %
365 11 / 12 91 %
492 11 / 15 73 %
614 2 / 2 100 %
696 8 / 9 88 %
Table value = 12.952 Chi squared = 7.83
Data are not heterogenous---- — Curve is a qood fit
*PD]_6 = 76 days PD04 = 455 days
PD50 = 186 days
(95% confidence interval for PD50 154 to 230 days)
*PD=positive day
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Figure 6 .
Figure 6 .
Figure 6 .
Table 6.2 
Legends to figures
Yield of M. leprae from armadillo livers is 
compared with ELISA absorbance for IgM 
antibodies to the Phen-Gl-1 antigen in 
sacrifice sera. Armadillos yielding 107 
51* leptae or less per gram of liver tissue are 
considered to yield 1 0 7 bacilli.
ELISA absorbances of’serial samples from 
resistant armadillos are related to their 
elapsed time from inoculation. Detectable 
antibody ELISA absorbance determined 
previously must exceed 710 on graph. Resistant 
armadillos do not appear to produce detectable 
IgM antibody to Phen-Gl-1 or production is 
irregular.
ELISA absorbances of serial samples from 
armadillos presenting from the wild with 
detectable antibodies to Phen-Gl-1 are 
compared to their histologic status before 
and after experimental infection with 
51* leprae* Horizontal dotted lines contain 
equivocal zone for interpretation of ELISA 
results and were derived previously.
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Absorbances below the lines indicate no 
significant antibody, those above the line 
indicate antibody present.
Figure 6.4 Mean ELISA absorbances for IgM antibodies to 
Phen-Gl-1 of 404 armadillo plasma samples are 
compared over 82 day intervals. Mean 
absorbance of each interval is plotted at the 
end of that interval or the last occurring day 
in the interval and bracketed by the SEM. 
Horizontal dotted lines (■•■) demark equivocal 
zone. Absorbances above this zone are 
considered positive and those below negative.
Vertical stipple line (----) marks 50%
positive day estimated by Litchfield-Wilcoxon 
and vertical dotted lines mark 95% confidence 
interval on the 50% day. Astericks (**) bound 
the 16% and 84% positive day by the same
method. Vertical broken line (--- ) marks
arithmetic mean day for detection of acid-fast 
bacteria in ear tissues by histologic methods. 
Figure demonstrates IgM antibodies become 
detectable in armadillos 186 days after 
experimental infection and continue to be 
detectable thereafter.
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Chapter 7, Abstract:
Enzyme-linked immunosorbent assays (ELISA) have been 
developed to detect antibodies to the phenolic-glycolipid-1 
(Phen-Gl-1) antigen of M. leprae. Statistical definitions 
for positive/negative interpretations in ELISA were derived 
by testing sera from 226 leprosy patients, 100 National 
Hansen's Disease Center (NHDC) staff members and 108 Pima 
Indians. Leprosy has not been diagnosed in the native 
American Indian and Pimas reside in a section of the United 
States where contact with leprosy would be rare. False 
positive reactions were not found in sera from Pima Indians. 
Therefore, Pimas probably represent "true negatives" for 
leprosy serology. IgM, IgA, and IgG antibodies to 
Phen-Gl-1 were detected in 46-62% of the leprosy patients 
tested. These antibodies were also detected in 12-14% of 
presumed healthy NHDC staff members. The predictive value 
of antibodies to Phen-Gl-1 is unknown. No significant 
correlation between ELISA absorbances and the bacterial 
index of lepromatous patients were found. Coefficients of 
correlation did not exceed 0.08. It is presumed that 
Phen-Gl-1 may persist in tissues to promote a humoral 
response even in absence of detectable bacilli. 
Anti-microbial therapy with dapsone had no significant 
effect on the serologic profiles of lepromatous patients 
with respect to serum IgM, IgA, IgG, C3 and specific IgM, 
IgA, IgG antibodies to the Phen-Gl-1 antigen. Patients 
suffering erythema nodosum leprosm (END had no discernable
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trends in antibodies to Phen-Gl-1. ENL was noted in 
patients both with and without detectable antibodies to 
Phen-Gl-1. Serological monitoring of patients to predict 
ENL does not seem feasible. The drug thalidomide had 
significant effect on levels of total serum IgM and 
specific IgM antibodies to Phen-Gl-1. Levels of other 
serum constituents or specific antibodies to Phen-Gl-1 were 
not significantly affected. Further studies on the 
persisting nature of this antigen and its possibility to 
stimulate a chronic antibody response may yield insight 
into the character of immune regulation in leprosy.
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Descriptions of antibody responses to M. leprae have 
always been complicated by a lack of specificity in antigen 
systems (61,100)# ^he bacilli bear a number of antigens on 
their cell surface which cross-react with other 
mycobacterial species^(94,136)  ^ Recently the phenolic- 
glycolipid-1 (Phen-Gl-1) antigen has been isolated from the 
tissues of armadillos experimentally infected with M. 
leprae. This antigen is chemically defined and apparently 
species specific for M. leprae (22,33,78)# <phe specificity 
of this antigen makes it useful for sero-epidemiologic 
studies (24) an(j provides a unique opportunity to observe 
M. leprae specific immune responses in the human host.
We present here an evaluation of the antibody 
responses to the phenolic-glycolipid-1 (Phen-Gl-1) antigen 
of M. leprae in leprosy patients, health care personnel in 
leprosy, and individuals of a leprosy virgin population.
MATERIALS AND METHODS
Serum Samples; a total of 435 serum samples were 
obtained for testing by enzyme-linked immunosorbent assay 
(ELISA) for antibodies to the phenolic-glycolipid-1 antigen 
of M. leprae - 226 leprosy patients at the National 
Hansen's Disease Center (NHDC) in Carville, Louisiana, 100 
presumed healthy NHDC staff members, and 108 Pima Indians 
from Phoenix, Arizona. Leprosy patients were classified 
according to the Ridley-Jopling scale (153) an(j presented
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to us as 196 lepromatous (LL), 6 borderline-lepromatous 
(BL), 14 mid-borderline (BB), and 11 tuberculoid (TT) 
patients. Leprosy patients were sampled either routinely 
or purposefully as they presented as new patients or were 
reactional. Relevant patient information collected 
included bacterial index; age; sex; reactional status; 
concentrations of total serum IgM, IgA, IgG and the C3 
protein of complement; treatment at the time of sampling 
according to 17 different regimens with 10 different drugs; 
as well as ELISA absorbancies for specific IgM, IgA and IgG 
antibodies to the phenolic-glycolipid-1 antigen. 
Bacteriological Index was calculated from the mean of 6 
skin scrapings according to the method of Ridley (X56)  ^
Total human serum IgM, IgA, IgG and the C3 protein of 
complement were quantitated by radial-immunodiffusion and 
reported in international units according to the 
recommendations of the manufacturer (Behring Diagnostics, 
Summerville, NJ). Drugs were used in standard therapeutic 
doses and considered here only as "in use" or not.
Sera from 100 NHDC staff members were taken routinely 
as part of yearly physical examinations. Samples were 
collected from individuals with no overt signs of leprosy 
and without regard for race, age, sex, or duties at the 
NHDC. Identifiers were removed from the samples by 
clinical laboratory staff and provided as left over 
diagnostic specimens.
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Sera from Pima Indians were collected by Dr. William 
Knowler, Chief, National Institutes of Health Field 
Investigations Unit, Phoenix, Arizona, and made available 
for this study. Sera had been taken as part of a program 
for diabetes screening and were stored frozen until use. 
The 108 samples represented Pima Indians of mixed age and 
sex, who had no overt signs of leprosy and were not 
undergoing immunosuppressive therapy.
Antigens Native purified phenolic-glycolipid-1 
(Phen-Gl-1) was prepared by Dr. Patrick Brennan (Colorado 
State University) and obtained through contract with the 
National Institute of Allergy and Infectious Diseases (Dr. 
Darrel Gwinn, Project Officer).
ELISA; Enzyme-linked immunosorbent assay (ELISA) 
was performed by a modification of the method previously 
described (198). Specifically, native purified phenolic- 
glycolipid-1 was mixed with 0.05 M carbonate buffer pH 9.2 
and suspended via sonication with a 3 mm probe at 70 watts 
for 3 minutes (Ultrasonics, Inc., Plainville, NY). The 
suspended antigen was diluted in the same buffer to a 
concentration of 2 jag in 50 jul, the volume which was added 
to 48 wells of a 96 well polyvinyl flatbottom microtiter 
plate (Cook Labs, Alexandria, VA). The remaining 48 wells 
received 50 jil of the carbonate buffer without antigen.
The plates were sealed with self-sticking cellophane tape 
and incubated overnight at 4°C. After incubation, the 
wells were washed 3 times for 7 minutes each wash with 200
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jjI of wash buffer consisting of 0.067 M phosphate buffered 
saline (PBS) pH 7.2 containing 1% bovine serum albumin 
(BSA) (Fraction V, Sigma, St. Louis, MO). After washing, 
the wells were blocked by the addition of 100 jil of 0 .067 M 
PBS pH 7.2 containing 5% BSA and incubated at 37°C for 1 
hour in a water bath. The wells were then washed as before 
and 50 ;ul of each serum sample optimally diluted in wash 
buffer was added to quadruplicate wells of the microtiter 
plate: 2 with antigen and 2 not containing antigen. The
plates were again sealed and incubated at 37°C for 45 
minutes when they were removed and washed as before. 
Horseradish peroxidase conjugated IgG fraction of goat 
anti-human IgM (mu chain specific), anti-human serum IgA 
(alpha chain specific), anti-human IgG (gamma chain 
specific) (Cappel Laboratories, Cochranville, PA) as 
appropriate and optimally diluted and wash buffer was added 
to each well in 50 jjI volumes. The plates were again 
sealed and incubated for 45 minutes at 37°C in a water bath 
when they were removed and washed as before. After 
washing, 50 p.1 of a solution containing 0.4 mg/ml ortho- 
phenylene-diamine (Sigma, St. Louis, MO) with 0.002% H2 O2 
in 0.1 M sodium acetate buffer pH 5.5 was added to each 
well. The plates were incubated at room temperature for 15 
minutes when the reaction was stopped with the addition of 
50 ^1 9 N HCl. The plates were read for absorbance at 492 
nm on a Titertek Multiscan photometer (Flow Labs, Richmond, 
VA). Mean absorbancies and coefficient of variation (CV)
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for each set (pair) of like wells were calculated. If the 
coefficient of variation exceeded 2 1 %, values were not 
taken and tests were repeated. Mean absorptions from 8 
wells receiving only conjugate and antigen were calculated 
and subtracted from the mean absorptions of paired antigen 
coated wells receiving test serum and conjugate. Likewise,
the mean absorptions from 8 wells not coated with antigen
and receiving only conjugate were subtracted from the mean 
absorptions of paired wells receiving test serum, conjugate
and containing antigen. Finally, the resulting absorbances
from test wells without antigen were subtracted from those 
of test wells with antigen. A quadruplicate series of 8 
two-fold dilutions for a high positive lepromatous serum 
was included in each test run to allow for correction from 
run to run by the method of least squares. Each serum was 
tested in at least 2 replicates and their average was used 
for analysis.
Optimal dilutions for the ELISA were determined as 
follows: The optimal dilution for enzyme-antibody
conjugates used in these ELISA assays was defined to be 
that dilution of conjugate resulting in the best correlated 
linear slope of absorbancies when reacted with serial 
dilutions between 0.1 ng and 10 ng of chromatographically 
purified human IgM, IgA or IgG as appropriate. For 
conjugate lots used in this study those effective optimal 
dilutions were anti-human IgM 1:3200, anti-human IgA
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1:12,000, and anti-human IgG 1:24,000. The optimal 
dilution of test serum was found by checkerboard 
titration (79). Serial dilutions of a battery of high 
positive and negative sera were reacted in microtiter wells 
containing 2 jug Phen-Gl-1 per well and detected by the 
optimally diluted conjugate. Optimal dilution for the 
serum was judged to be that dilution which resulted in the 
greatest difference in absorbancies between the positive 
and negative sera. In all cases for use in this study, 
that dilution was found to be 1:35 in the tube.
Statistical Analysis: Analysis of data were
performed on an IBM 5320 using standard statistical 
programs in the Statistical Analysis Systems (SAS) 
commercial program package (36,192)#
RESULTS
ELISA-IqM; Evaluation of Positive and Negative 
Reactions: Sera from 226 leprosy patients, 100 National
Hansen's Disease Center (NHDC) staff members, and 108 Pima 
Indians were screened by ELISA for IgM antibodies to the 
phenolic-glycolipid-1 antigen. The resulting absorbancies 
were pooled and examined in a frequency histogram 
(Fig. 7.1). Inspection of the histogram showed the 
population to be positively skewed and a Pearson's 
coefficient of skewness was calculated to be +1.4. 
Non-specific reaction in ELISA would be expected to occur
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randomly over a normal distribution. Reactions of specific 
antibodies with the phenolic-glycolipid-1 antigen in ELISA 
would not be random and they would be expected to deviate 
from normal. The positive skew of the sample population 
indicated that the ELISA detected specific antibodies to 
the Phen-Gl-1 antigen.
To determine if the ELISA described differences 
between the patient, staff, and Pima groups, their 
respective absorbances were examined in a scattergram (Fig. 
1.2). Inspection of the scattergram suggested that the 
groups were different. Analysis of variance confirmed that 
patients were significantly different (p < 0 .0 0 1 ) from 
staff and pimas while staff and Pimas were also 
significantly different (p < 0.05). A test for extreme 
values revealed significant outliers in the staff group but 
did not detect outliers in the Pima group. Distributions 
of the individual groups were also examined. Patients and 
staff were both positively skewed with a Pearson's 
coefficient of skewness: 1.1 patient and 1.4 staff. The
Pima group was more normally distributed having a Pearson's 
coefficient of skewness of only 0.18.
The approximately normal distribution of ELISA 
absorbancies from the Pima group suggested random, 
non-specific detection of IgM antibodies. The positively 
skewed distribution of patients and staff probably 
reflected reaction of specific IgM antibodies to the 
Phen-Gl-1 antigen. Thus, a 99% confidence interval around
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the distribution of the Pima absorbancies describes the 
interval of non-specific detection in the ELISA-IgM, and 
can be used for positive and negative interpretations. By 
Z-transformation, the upper boundary of this interval was 
calculated to be 0.346. Absorbances below this upper limit 
are within the confidence of non-specific reaction and may 
be called negative. Absorbancies greater than this upper 
limit exceed the confidence of non-specific reaction and 
may be called positive (as they reflect specific reaction 
of IgM antibodies to the Phen-Gl-1 antigen). Using these 
definitions, 0% (0/108) Pima Indians were positive for IgM 
antibodies to the Phen-Gl-1 antigen. However, 12% (12/100) 
NHDC staff members and 62% (142/226) leprosy patients were 
positive for IgM antibodies to the Phen-Gl-1 antigen of M. 
leprae.
ELISA-IqA; Evaluation of Positive and Negative 
Reactions; The combined sample population was also 
tested by ELISA for IgA antibodies to the Phen-Gl-1 antigen. 
As described above, the resulting absorbances were 
inspected in a frequency histogram (Fig. 7.3). Inspection 
of the frequency histogram suggested a definite positive 
skew and a Pearson's coefficient of skewness was calculated 
to be 1.6. A positive skew suggested that the ELISA 
detected specific IgA antibodies to the phenolic- 
glycolipid-1 antigen. Closer scrutiny of these groups in a 
scattergram (Fig. 7.4) suggested that they were different. 
Analysis of variance described that patients were
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significantly different from both staff and Pima's (p < 
0.001) while staff and Pimas were likewise significantly 
different (p < 0.01). A test for extreme values found 
significant outliers in the patient and staff groups but 
did not identify significant outliers in the Pima group. 
Additionally, the distributions of the patient and staff 
groups showed positive skew (Pearson’s coefficient of 
skewness: patients 0.99, staff 3.19). The distribution of 
the Pima group was more normal having a Pearson's 
coefficient of skewness of only 0.002. The approximately 
normal distribution reflected the detection of only 
non-specific antibodies while the positive skew of patients 
and staff suggested detection of specific antibodies to the 
Phen-Gl-1 antigen. Therefore, a 99% confidence interval 
constructed about the distribution of the Pima group would 
describe the interval of non-specific reaction in the ELISA 
and the boundaries of this interval could be used for 
positive and negative interpretations. Using 
Z-transformation, the upper boundary of the 99% confidence 
interval about the Pima group was found to be 0.274. All 
(108/108) ELISA absorbancies from the Pima group were found 
in this interval and the Pimas were interpretable as 
negative. However, 13% (13/100) NHDC staff member 
absorbancies and 46% (106/226) leprosy patient absorbancies 
were found outside this interval suggesting specific 
reaction and detection of specific IgA antibodies to the 
Phen-Gl-1 antigen.
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ELISA IgG: Evaluation of Positive and Negative
Reactions; Likewise, IgG antibodies of the combined 
sample population presented a positive skew of 1.23 in the 
frequency histogram and scattergram (Fig. 7.5 and 7.6). 
Analysis of variance indicated there were significant 
differences in the sample population and showed patients 
were significantly different from both staff and Pimas (p < 
0.001), while again the Pima group was significantly 
different from staff (p < 0.01). Significant outliers were 
not identified in the Pima group but were found in the 
patient and staff groups. The distribution of the Pima 
group had a skew of only 0 .0 1 ; but, the staff and patients 
were positively skewed with a Pearson's coefficient of 1.22 
and 0.827 respectively. Thus, pimas did not reflect any 
disturbance in their distribution caused by specific 
reaction of antibodies to the Phen-Gl-1 antigen; while 
patients and staff demonstrated a positive skew, probably 
as the result of specific reaction of antibodies with the 
phenolic-glycolipid-1 antigen. A 99% confidence interval 
about the distribution of the Pima's describes the interval 
of non-specific reaction in the ELISA-IgG and the upper 
limit of that interval could be used for interpretation of 
positive and negative reactions. Using z-transformation, 
that upper limit was found to be 0.362. Using these 
definitions, 100% (108/108) Pima Indians had ELISA 
absorbancies interpretable as negative. However, 14% 
(14/100) NHDC staff members and 47% (108/226) leprosy
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patients had ELISA absorbancies interpretable as positive 
for IgG antibodies to the Phen-Gl-1 antigen of M. leprae.
Antibodies by Disease Classification; The patient 
group was sorted according to their respective disease 
classification as lepromatous (LL), borderline-lepromatous 
(BL), mid-borderline (BB), and tuberculoid (TT) (153), fj0 
borderline-tuberculoid patients were sampled. ELISA 
absorbancies for IgM, IgA, and IgG antibodies to the 
Phen-Gl-1 antigen resulting from patient sera of these 4 
classes are presented in a scattergram (Figs. 7.7, 7.8, 7.9 
respectively).
Lepromatous patients dominated the sample and appeared 
to exhibit the highest ELISA absorbancies for antibodies to 
the Phen-Gl-1 antigen. The level of ELISA absorbancies 
decreased when the disease classification became 
tuberculoid (TT). Antibodies of all classes (IgM, IgA, and 
IgG) were detected in lepromatous (LL), borderline- 
lepromatous (BL), and mid-borderline (BB) patients. A 
single serum sample from a tuberculoid patient had ELISA 
absorbancies interpretable as positive for IgG antibodies 
to the Phen-Gl-1 antigen. Neither IgM nor IgA antibodies 
were detectable in the sera from tuberculoid (TT) patients.
The patients under study included both active and 
inactive cases on various regimens of treatment. Serum 
samples were taken at a single point in time and 
longitudinal screening was not sought. On a percentage 
basis, 63% (123/196) of the lepromatous (LL) patients, 100%
(6/ 6 ) of the borderline-lepromatous (BL) patients, and 28% 
(4/14) of the mid-borderline (BB) patients had detectable 
IgM antibodies to the phenolic-glycolipid-1 antigen. 
Likewise, IgA antibodies were detected in 47% (92/196) of 
the lepromatous (LL) patients, 6 6% (4/6) of the 
borderline-lepromatous (BL) patients, and 14% (2/14) of the 
mid-borderline (BB) patients; while IgG antibodies were 
detected in 48% (9 3/196) of the lepromatous (LL) patients, 
50% (3/6) of the borderline-lepromatous (BL) patients, 29% 
(4/14) of the mid-borderline (BB) patients, and 9% (1/11) 
of the tuberculoid (TT) patients. More than 1 antibody 
isotype was detected in 32% (72/226) of the patient sera, 
and all 3 antibody isotypes were detected in 18% (40/226) 
of the patient sera tested.
There were no significant trends with regard to 
detection of antibody isotypes in combination. While IgM 
antibody was detected more frequently, it could equally 
well be found independently or in combination with IgA or 
IgG. Likewise, IgA and IgG showed no significant trend 
with regard to detection in combination.
Correlation of ELISA with Bacterial Index (BI);
ELISA absorbancies of IgM, IgA and IgG antibodies to the 
Phen-Gl-1 antigen and the bacterial index (BI) were 
compared by regression. Previous comparisons had shown 
that serologic profiles of patients treated only with 
dapsone or rifampin or on combined therapy of dapsone and 
rifampin were not significantly different. For comparison
of ELISA absorbances according to BI only polar lepromatous 
patients treated with dapsone or dapsone in combination 
with rifampin, were compared (Figs. 7.10, 7.11, 7.12). No 
significant correlations between ELISA absorbancies and BI 
was found. Correlation coefficients (r) did not exceed 
0.08. Slopes of the regression lines for ELISA 
absorbancies of IgM, IgA and IgG antibodies to the 
phenolic-glycolipid-1 antigen with respect to BI were not 
significant. The slope of the IgG regression line was 
negative. The 95% confidence intervals about the 
regression lines were wide and disparate. The 95% 
confidence interval for ELISA-IgM absorbancies with respect 
to BI exceeded the boundaries of the plot.
Levels of Phen-Gl-1 Antibodies with Treatment:
ELISA absorbancies for specific antibodies to the Phen-Gl-1 
antigen were compared for lepromatous patients undergoing 
different therapeutic regimens. Concentrations of total 
serum IgM, IgA, IgG and the C3 protein of complement were 
also compared. Concentrations of total serum 
immunoglobulins and C3 were not available for all patients. 
Sample sizes of the groups were also different and the 
varying degrees of freedom (df) are recorded in the 
appropriate tables. Significant differences between the 
groups were described by analysis of variance and a 
Bonferroni (Dunn) t-test. Statistical comparisons using 
these methods are quite conservative and the Bonferroni
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t-test controls the type I experimental error but generally 
has the higher type II error rate than Tukey's (36,192)#
The selected groups were evaluated for differences 
between treatment, sex, and treatment-sex interactions. 
Significant differences influenced by sex were not observed 
in ELISA absorbancies for antibodies to the phenolic- 
glycolipid-1 antigen, nor in concentrations of total 
immunoglobulins. Significant differences influenced by sex 
were observed in C3 concentrations. When sex had a 
significant influence on C3 but treatment did not, those 
differences were reported here as not significant. No 
significant differences in C3 concentrations are observed 
in the treatments examined.
Patients untreated for active leprosy and patients on 
dapsone anti-microbial therapy for leprosy are compared in 
Table 7.1. No significant differences were observed 
between dapsone treated patients and untreated patients.
Patients continuing on dapsone therapy but undergoing 
a reactional episode of erythema nodosum leprosum (ENL) are 
compared to non-reactional dapsone treated patients in 
Table 7.2. Total serum IgM antibodies were significantly 
higher in the reactional patient. Total serum IgA, IgG, C3 
and specific antibodies to the Phen-Gl-1 antigen were not 
observed to be significantly different in the dapsone 
treated patient and reactional patient on the same therapy. 
Patients with ENL had ELISA-IgM, IgA, and IgG absorbancies 
ranging from positive to undetectable in the ELISA.
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Patients on dapsone therapy and undergoing ENL are 
compared to patients on therapy with a combination of 
dapsone and thalidomide (the latter as part of treatment 
for ENL) in Table 7.3. Patients treated with thalidomide 
have significantly lower levels of total serum IgM than 
patients in ENL and not taking thalidomide. Total serum 
IgA, IgG and C3 were not significantly different. ELISA 
absorbancies for IgM antibodies to the Phen-Gl-1 antigen 
were also significantly lower in the thalidomide treated 
patient. Specific IgA and IgG antibodies were not 
significantly affected by treatment with thalidomide.
Patients on dapsone therapy but not in ENL were 
compared to patients on combined therapy of dapsone and 
thalidomide in Table 7.4. The dapsone-thalidomide treated 
patient had significantly lower total serum IgM and 
ELISA-IgM for antibodies to the Phen-Gl-1 antigen than 
patients on dapsone only. Concentrations for total serum 
IgA, IgG and C3, as well as specific IgA and IgG ELISA 
absorbancies, were not shown to be significantly different.
DISCUSSION
Using ELISA, IgM, IgA and IgG antibodies to the 
phenolic-glycolipid-1 antigen of M. leprae were detectable 
in the sera of leprosy patients. These antibodies were 
also detectable in sera from staff members at the National 
Hansen's Disease Center (NHDC), but were not detectable in
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sera from Pima Indians. Leprosy has not been diagnosed in 
the native American Indian and Pima's reside in a section 
of the United States where reports of leprosy are extremely 
rare (58,68)  ^ In that manner, Pima Indians might be 
considered as leprosy virgin and sera from this group may 
be used as negative controls in leprosy serology.
ELISA yield results in objectively derived numeric 
absorbance units that are readily used in statistical 
analysis. Using ELISA absorbancies for sera from Pima 
Indians, statistical definitions for interpretation of 
positive/negative ELISA results were derived. Pima Indian 
sera were shown to react non-specifically over an 
approximately normal distribution in ELISA for antibodies 
to the Phen-Gl-1 antigen. ELISA absorbancies for sera from 
leprosy patients and NHDC staff did not result in normal 
distributions but showed positive skew. This skew 
reflected reaction of specific antibodies with the 
Phen-Gl-1 antigen. A 99% confidence interval constructed 
about the Pima distribution described the range for 
non-specific reactions in the ELISA. The upper boundary of 
that interval described the probable upper limit for 
non-specific reaction and was used in definition of 
positive and negative in ELISA absorbancies.
Using these definitions, antibodies to the Phen-Gl-1 
antigen were detected in 12-14% of presumed healthy NHDC 
staff members. Antibody prevalence rates have not 
previously been reported for health care delivery personnel
134
in leprosy. Antibodies to the phenolic-glycolipid-1 
antigen have been reported in family members and contacts 
of leprosy patients (24,217), Some NHDC staff members come 
in constant contact with leprosy patients and are likely 
hyper-exposed to M. leprae in their environment. Leprosy 
personnel have been noted to have higher relative risk 
rates for contracting leprosy than other groups (51),
These data indicate that staff members also have a high 
probability of developing antibodies to M. leprae. At this 
time, the relative risk, as may be ascribed to persons with 
a known environmental exposure to M. leprae and having 
positive serological indications, cannot be discerned. The 
predictive value of IgM antibodies to Phen-Gl-1 is a 
continuing research interest for sero-epidemiology.
Leprosy patients may be classified according to the 5 
group scheme of the Ridley-Jopling scale (153), This 
method groups patients according to their own disease 
status and recognizes the split anergy of the leprosy 
immune response (26,31,101), Polar lepromatous patients 
have a predominant humoral immune response but lack 
competent cell mediated immunity to M. leprae. Patients to 
the tuberculoid pole have a predominant cell-mediated 
immune response but lack strong humoral immunity to M. 
leprae. Patients in this study also seemed to reflect that 
dichotomy with regard to IgM, IgA and IgG antibodies to the 
Phen-Gl-1 antigen. These observations are in keeping with 
those of previous investigators who noted a decline in IgM
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or total immunoglobulins as patient classification moved 
from polar lepromatous (LL) to polar tuberculoid (TT)
(19,26,133)_ ELISA-IgM absorbancies in lepromatous 
patients also were the highest recorded. IgM was the most 
commonly detected isotype in leprosy patients. These data 
are in keeping with assertions by previous investigators 
that IgM antibodies to Phen-Gl-1 may be the most 
appropriate isotype for sero-epidemiology (24,217)_
However, IgM, IgA and IgG antibodies to the Phen-Gl-1 
antigen were also detectable in persons environmentally 
exposed to M. leprae and in treated and untreated leprosy 
patients. Though no discernable trends could thus far be 
revealed in detecting combinations of antibodies, isotypes 
other than IgM may have relevant roles in sero-epidemiology 
and clinical investigations.
To determine if levels of Phen-Gl-1 antibodies in 
lepromatous patients might be affected by their status at a 
given point in time, selected groups were examined. Using 
extracts of M. leprae, previous investigators have asserted 
correlation between the level of antibody activity and the 
bacterial load of the lepromatous patient (130,131)e ELISA 
absorbancies for IgM, IgA, and IgG antibodies to the 
phenolic-glycolipid-1 antigen had no significant 
correlations with the bacterial index of lepromatous 
patients on anti-microbial therapy. As shown in Figures 
7.9, 7.10, and 7.11, even lepromatous patients with a BI of 
0 may have detectable antibodies to the Phen-Gl-1 antigen.
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The persistence of detectable antibody in patients with a 
BI of 0 probably indicates that this antigen persists after 
acid-fast bacilli have been cleared. Granulomas of 
resolving lepromatous patients contain no detectable 
bacilli but foamy macrophages may be detected (85). Foamy 
inclusions in these macrophages may be lipid from M. leprae 
and could be responsible for the persisting humoral 
response.
To determine if serologic profiles of lepromatous 
patients were influenced by drug therapy or erythema 
nodosum leprosum (ENL), selected groups were examined. 
Concentrations of total serum immunoglobulins, the C3 
protein of complement as well as ELISA absorbancies for 
IgM, IgA and IgG antibodies to the Phen-Gl-1 antigen, were 
tested for significant differences. The groups were 
selected to assess 4 phases of the disease in the 
lepromatous patient: untreated new patient, anti- 
microbially treated, reactional, and treated for reaction.
When an untreated leprosy patient first presents, he 
is started on a course of anti-microbial therapy. Dapsone 
is an anti-microbial in common use for the treatment of 
leprosy. In this study, patients on anti-microbial therapy 
with dapsone had a similar serologic profile to untreated 
patients. Previous reports have suggested that 
anti-microbial therapy over time tends to decrease levels 
of IgM antibodies (131,132,135)# These reports were based 
on longitudinal sampling of individual patients.
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Longitudinal samples were not tested in this study and 
individual patients were noted to be highly heterogeneous. 
Previous studies have also noted great heterogeneity in 
antibody responses from leprosy patients of similar groups
(130,133)  ^ Therefore, the observations reported here do 
not contradict those previous conclusions.
Patients undergoing an episode of erythema nodosum 
leprosum (ENL) had significantly elevated levels of total 
serum IgM over non-reactional dapsone treated patients.
ENL is thought to be an Arthus type hypersensitivity 
reaction possibly mediated by IgM antibodie" (29,87,178, 
212,214)  ^ previous investigators have noted elevated serum 
IgM during the reactional episode and hypothesized that 
their reaction with M. leprae antigens might initiate 
ENL (30,170,178)  ^ jf ^he phen-Gl-1 antigen is involved in 
ENL then one might expect changes in ELISA absorbances of 
ENL patients depending on whether: a) there was new 
production of antibody? or b) there was excess consumption 
of antibody. No changes in ELISA absorbances would be 
expected if: c) there is a relative balance between 
production and consumption of Phen-Gl-1 antibodies in ENL; 
or d) antibodies to Phen-Gl-1 are not involved in ENL. In 
the present study, ELISA absorbances for specific 
antibodies to Phen-Gl-1 were not significantly different in 
reactional patients. Some patients in ENL did not have 
detectable antibody to Phen-Gl-1. No trends were revealed 
in detecting antibody that might make serological
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monitoring useful in predicting ENL. Therefore, these data 
provide no evidence that Phen-Gl-1 is directly involved in 
the pathogenesis of ENL.
On the other hand, patients treated with thalidomide 
had significantly depressed ELISA-IgM absorbancies for 
antibodies to the Phen-Gl-1 antigen. Levels of total serum 
IgM were also significantly lower. Thalidomide has been 
shown to polyclonally suppress de novo IgM production to 
T-dependent antigens but not to T-independent antigens 
(175,176) # >rhe suppression seen here in total serum IgM 
and specific IgM antibodies may be the result of polyclonal 
suppression or could indicate that IgM antibodies to the 
phenolic-glycolipid-1 antigen are consumed during ENL. If 
consumed, their production is inhibited by the action of 
thalidomide. Therefore suppression of IgM antibodies to 
the Phen-Gl-1 antigen by the action of thalidomide suggests 
that phen-Gl-1 is a T-dependent antigen of M. leprae. This 
is in keeping with the appearance of IgM antibody to 
Phen-Gl-1 in M. leprae infected athymic nude mice only 
after reconstitution with spleen cells form syngeneic 
donors (unpublished observations).
In summary, statistical definitions have been 
developed for the interpretation of positive and negative 
reactions in ELISA for IgM, IgA, and IgG antibodies to the 
phenolic-glycolipid-1 antigen of M. leprae. Using these 
definitions, IgM, IgA, and IgG antibodies were detectable 
in the sera of leprosy patients, and more commonly
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detectable in those not classified as tuberculoid. These 
antibodies were also detectable in presumably healthy 
individuals at least some of whom are environmentally 
exposed to M. leprae. The predictive value of detecting 
these antibodies in persons environmentally exposed to M. 
leprae cannot be ascertained. False positive reactions for 
antibodies to the Phen-Gl-1 antigen were not found in a 
group of native American Pima Indians. While not immune to 
mycobacterial infections, leprosy has never been diagnosed 
in the native American Indian and Pimas reside in a region 
of the United States where contact with M. leprae would be 
rare. Therefore, Pimas probably represent "true negatives" 
for leprosy serology. There appear to be no significant 
correlations between ELISA absorbancies for antibodies to 
the Phen-Gl-1 antigen and the bacterial index of the 
lepromatous patient. It is presumed that this lipid 
antigen may persist in tissues to promote a humoral 
response even in the absence of detectable acid-fast 
bacilli. Anti-microbial therapy with dapsone had no- 
detectable effect on the serologic profiles of lepromatous 
patients. Antibodies to the phenolic-glycolipid-1 antigen 
could not be implicated directly in the pathogenesis of ENL. 
There were no discernible trends in ELISA absorbancies for 
antibodies to this antigen in patients suffering ENL and 
prospective monitoring of patients by ELISA in hopes of 
predicting ENL does not seem feasible. The drug 
thalidomide had significant effect on IgM antibodies to
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this antigen and Phen-Gl-1 may be a T-dependent antigen of 
M. leprae. Further studies on the persisting nature of 
this antigen and its ability to stimulate a chronic 
T-dependent response may yield interesting insight into the 
character of immune regulation in leprosy.
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Table 7.1 Serologic profile of untreated 
lepromatous patients and lepromatous patients 
treated with dapsone
DAPSONE UNTREATED
X S X S df P
Serum*
IgM 197 83 198 112 24 NS
IgA 263 102 242 131 24 NS
IgG 188 35 186 56 24 NS
C3 10 6 23 101 12 24 NS
ELISA#
IgM 765 464 751 436 36 NS
IgA 329 293 530 386 36 NS
IgG 430 267 537 385 36 NS
x=mean; s=standard deviation; df=degrees freedom; 
£=probability by t-test; NS=not significant 
levels are expressed for total serum concentration in 
IU/dl
#ELISA absorbances for specific antibodies to Phen-Gl-1 
antigen.
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Table 7.2. Serologic profile of lepromatous patients 
treated with dapsone but not in reaction 
and those treated with dapsone but undergoing 
erythema nodosum leprosum.
DAPSONE REACTIONAL
X S X S df P
Serum*
IgM 197 83 264 225 23 0.05
IgA 263 10 2 273 147 23 NS
IgG 188 35 19 6 135 23 NS
C3 106 23 99 13 23 NS
ELISA#
igM 765 464 949 342 33 NS
IgA 329 29 3 561 413 33 NS
IgG 430 267 361 221 33 NS
x=mean; s=standard deviation; df=degrees freedom; 
p=probability by t-test; NS=not significant 
levels are expressed for total serum concentration in 
IU/dl
$ELISA absorbances for specific antibodies to Phen-Gl-1
antigen.
143
Table 7.3. Serologic profile of lepromatous patients 
on dapsone and those on combination therapy 
of dapsone with thalidomide.
DAPSONE THALIDOMIDE
X S X S df P
Serum*
IgM 19 7 83 151 62 28 0.05
IgA 263 10 2 197 101 28 NS
IgG 188 35 169 55 28 NS
C3 10 6 23 100 12 28 NS
ELISA#
IgM 765 464 377 328 39 0.05
IgA 329 29 3 224 19 2 39 NS
IgG 430 267 523 235 39 ■ NS
x=mean; s=standard deviation; df=degrees freedom; 
p=probability by t-test; NS=not significant 
levels are expressed for total serum concentration in 
IU/dl
“ELISA absorbances for specific antibodies to Phen-Gl-1
antigen.
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Table 7.4. Serologic profile of lepromatous patients 
on dapsone in reaction with erythema nodosum leprosum 
and patients on combination therapy 
of dapsone with thalidomide
REACTIONAL THALIDOMIDE
X S X S df P
Serum*
IgM 264 225 151 62 13 0.05
IgA 27 3 147 197 101 13 NS
IgG 19 6 135 169 55 13 NS
C3 99 13 100 12 13 NS
ELISA#
IgM 949 342 377 328 18 0.05
IgA 561 413 224 19 2 18 NS
IgG 361 221 523 235 18 NS
x=mean; s-standard deviation; df=degrees freedom; 
p=probability by t-test; NS=not significant 
levels are expressed for total serum concentration in
#ELISA absorbances for specific antibodies to Phen-Gl-1
antigen.
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Table 7.5 
Legends to figures.
Figure 7.1 Frequency histogram of ELISA absorbances for 
IgM antibodies to Phen-Gl-1 from 226 leprosy 
patients, 100 NHDC staff, and 108 Pima Indians. 
Absorbance is X 1000 and plot is over 30 equal 
class intervals of 50 absorbance units each.
Figure 7.2 Scattergram of ELISA absorbances for IgM
antibodies to Phen-Gl-1 sorted according to 
group. Absorbance is coded X 1000. Bars mark 
the mean of each group. Brackets were found by 
Z-transformation and indicate the upper 99% 
confidence limit of each distribution. 
Horizontal line at 346 demarks limit for 
non-specific ELISA absorbances as described by 
Pima distribution.
Figure 7.3 Frequency histogram of ELISA absorbances for 
IgA antibodies to Phen-Gl-1 from 226 leprosy 
patients, 100 NHDC staff, and 108 Pima Indians. 
Absorbance is X 1000 and plot is over 30 equal 
class intervals of 50 absorbance units each.
Figure 7.4 Scattergram of ELISA absorbances for IgA
antibodies to Phen-Gl-1 sorted according to
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group. Absorbance is coded X 1000. Bars mark 
the mean of each group. Brackets were found by 
Z-transformation and indicate the upper 99% 
confidence limit of each distribution. 
Horizontal line at 274 demarks limit for 
non-specific ELISA absorbances as described by 
Pima distribution.
Figure 7.5 Frequency histogram of ELISA absorbances for 
IgG antibodies to Phen-Gl-1 from 226 leprosy 
patients, 100 NHDC staff, and 108 Pima Indians. 
Absorbance is X 1000 and plot is over 30 equal 
class intervals of 50 absorbance units each.
Figure 7.6 Scattergram of ELISA absorbances for IgG
antibodies to Phen-Gl-1 sorted according to 
group. Absorbance is coded X 1000. Bars mark 
the mean of each group. Brackets were found by 
Z-transformation and indicate the upper 99% 
confidence limit of each distribution. 
Horizontal line at 363 demarks limit for 
non-specific ELISA absorbances as described by 
Pima distribution.
Figure 7.7 Scattergram of ELISA absorbances for IgM 
antibodies to Phen-Gl-1 for 226 leprosy 
patients sorted according to classification:
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LL=lepromatous, BL=borderline lepromatous, 
BB=mid-borderline, TT=tuberculoid
Figure 7.8 Scattergram of ELISA absorbances for IgA 
antibodies to Phen-Gl-1 for 226 leprosy 
patients sorted according to classification. 
LL=lepromatous, BL=borderline lepromatous, 
BB=mid-borderline, TT=buberculoid.
Figure 7.9 Scattergram of ELISA absorbances for IgG 
antibodies to Phen-Gl-1 for 226 leprosy 
patients sorted according to classification. 
LL=lepromatous, BL-borderline lepromatous, 
BB=mid-borderline, TT=tuberculoid.
Figure 7.10 Correlation by regression of ELISA absorbances 
for IgM antibodies to Phen-Gl-1 and bacterial 
index of nonreactional LL patients on therapy 
with dapsone or dapsone in combination with 
rifampin. Absorbance is coded X 1000.
Correlation coefficient=(r). Broken line (--- )
is regressed, not significant. Confidence 
interval of regressed line exceeded the 
boundaries of the plot.
Figure 7.11 Correlation by regression of ELISA absorbances 
for IgA antibodies to Phen-Gl-1 and
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bacterial index of nonreactional LL patients on 
therapy with dapsone or dapsone in combination 
with rifampin. Absorbance is coded X 1000.
Correlation coefficient=(r). Broken line (--- )
is regressed, not significant. Solid line is 
95% confidence interval of regression line.
Figure 7.12 Correlation by regression of ELISA absorbances 
for IgG antibodies to Phen-Gl-1 and bacterial 
index of nonreactional LL patients on therapy 
with dapsone or dapsone in combination with 
rifampin. Absorbance is coded X 1000.
Correlation coefficientsr). Broken line (--- )
is regressed, not significant. Solid line is 
95% confidence interval of regression line.
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SUMMARY
In summary, enzyme-linked immunosorbent assays (ELISA) 
have been developed to detect antibodies to a chemically 
defined and apparently species specific phenolic- 
glycolipid-1 (Phen-Gl-1) antigen of Mycobacterium leprae. 
Previous serologic procedures have lacked both sensitivity 
and specificity as they relied on undefined antigen 
mixtures and were complicated by the plethora of cross 
reacting antigenic determinates of mycobacterial species. 
The assays have been developed with statistical definitions 
for interpretation of positive and negative reactions.
They are developed for application in the two major hosts 
of leprosy: man and armadillos.
The immunoglobulin IgM is an evolutionarily primitive 
molecule. Serologic cross reactivities of IgM antibodies 
have been noted among a number of species. Such cross 
reactivity was also noted between human and armadillo IgM. 
Using commercially prepared enzyme-anti-antibody conjugates 
directed against human IgM, armadillo IgM antibodies are 
detectable by ELISA. The ELISA-IgM v. Phen-Gl-1 was 
developed for use in armadillos and evaluation showed it to 
be highly sensitive and specific. The assay was optimized 
to have a calculatable specificity of 100%. Such high 
specificity is especially useful in sero-epidemiologic 
studies.
161
162
Leprosy is zoonotic in the armadillo, Dasypus 
novemcinctus. The origin of these infections has been the 
subject of great debate. Understanding their origin may 
have impact on our understanding of the transmission and 
distribution of leprosy. A retrospective serological 
survey of armadillos taken in years pre-dating their use in 
leprosy, found antibodies to the phenolic-glycolipid-1 
antigen in 17 of the armadillos examined. These antibodies 
were not absorbable with other mycobacterial species and 
presumably were elicited as a result of contact with M. 
leprae. Thus, the disease of armadillos appears to be a 
naturally acquired zoonosis.
The transmission of leprosy is not yet understood. 
Studies of the disease are complicated by a long incubation 
period, low susceptibility, and high mobility of the human 
population. However, naturally acquired leprosy is 
zoonotic in the armadillo and may be used as an animal 
model to study the transmission of leprosy. Transmission 
may be affected by environmental conditions, population 
characteristics or other intricacies in the transmission of 
leprosy. To better develop the armadillo as an animal 
model for the transmission of leprosy, prevalence rates 
were estimated in armadillos from two parishes in Louisiana. 
Modern antibody prevalence rates for Louisiana averaged 
12.5%. variations in prevalence were noted between 
Louisiana and Florida where there have been no reports of 
zoonotic leprosy. These variations must be the result of
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some factors affecting the transmission of the disease. To 
better understand these factors, data base information 
concerning the leprosy positive armadillo habitat of 
Louisiana has been developed. Future comparison of 
prevalence in armadillos of similar and different habitats 
will aid our understanding of factors that influence 
transmission of leprosy.
M. leprae have not been cultivated on artificial media 
and must be propagated in vivo. The armadillo (Dasypus 
novemcinctus) is well developed as a host for M. leprae, 
and is evolving as an animal model for the study of leprosy. 
Understanding the immunologic responses of armadillos as a 
result of experimental infection with leprosy will advance 
their use as models and may impact the efficiency of in 
vivo propagation. Testing of armadillos for IgM 
antibodies to the phenolic glycolipid-1 antigen showed that 
there is a slow initial IgM response to this antigen 
requiring an average of 186 days to become detectable by 
the ELISA. These antibodies appear to persist over the 
course of infection and may be detected for up to 1140 days. 
Armadillos that succumb to M. leprae infection develop high 
antibody levels and ELISA absorbances of greater or less 
than 1.2 may be used to predict the outcome of an 
experimental infection 97% of the time. Armadillos that do 
not succumb to experimental infection appear to have an 
irregular or absent IgM antibody response to the phenolic- 
glycolipid-1 antigen. Antibodies were earlier and more
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reliable indicators of infection than previously used 
histologic monitors. These response profiles may be used 
to predict resistance in armadillos both early and late in 
the course of experimental infection and will have impact 
on the efficiency of in vivo propagation. Armadillos with 
naturally acquired leprosy were also noted to have 
irregular response patterns. Pre-screening of armadillos 
to identify animals with a wild infection will aid 
researchers in preserving their culture strains of M. 
leprae and will allow identification of animals that would 
be unsuitable for modeling studies. Knowledge of the 
immunologic responses of armadillos to M. leprae antigens 
may benefit our understanding of the immune response of 
human leprosy patients.
Leprosy has its greatest impact as a severe infection 
of man. The leprosy patient presents with a complex array of 
clinical and immunologic symptoms, and management of the 
disease is complicated. To determine if serologic monitoring 
may have impact on the diagnosis and management of human 
leprosy, ELISA were developed. Statistical definitions were 
developed for the interpretation of positive and negative 
reactions in ELISA for IgM, IgA, and IgG antibodies to the 
phenolic glycolipid-1 antigen of M. leprae. Using these 
definitions, IgM, IgA, and IgG antibodies were detectable in 
the sera of leprosy patients, and more commonly detectable in 
those not classified as tuberculoid. These antibodies were 
also detectable in presumably healthy individuals who are
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environmentally exposed to M. leprae. The predictive value 
of detecting these antibodies in persons environmentally 
exposed to M. leprae cannot be ascertained. False positive 
reactions for antibodies to the phenolic-glycolipid-1 antigen 
were not found in a group of native American Pima Indians. 
While not immune to mycobacterial infections, leprosy has 
never been diagnosed in the native American Indian and Pimas 
reside in a region of the United States where contact with M. 
leprae would be rare. Therefore, Pimas probably represent 
"true negatives" for leprosy serology. There appear to be no 
significant correlations between ELISA absorbancies for 
antibodies to the phenolic-glycolipid-1 antigen and the 
bacterial index of the lepromatous patient. It is presumed 
that this lipid antigen may persist in tissues to promote a 
humoral response even in the absence of detectable acid-fast 
bacilli. Anti-microbial therapy with dapsone had no 
significant effect on the serologic profiles of lepromatous 
patients. Antibodies to the phenolic-glycolipid-1 antigen 
could not be implicated directly in the pathogenesis of ENL. 
There were no discernible trends in ELISA absorbancies for 
antibodies to this antigen in patients suffering ENL and 
prospective monitoring of patients by ELISA in hopes of 
predicting ENL does not seem feasible. The drug thalidomide 
had significant effect on IgM antibodies to this antigen and 
phenolic-glycolipid-1 may be a T-dependent antigen of M. 
leprae. Further studies on the persisting nature of this 
antigen and its propensity to stimulate a chronic T-dependent
166
response, may yield interesting insight into the character of 
immune regulation in leprosy.
167
REFERENCES
1. Abe M: Anti-M. leprae antibodies in leprosy patients as
demonstrated by indirect inuunofluorescence. Int. J. Lepr. 
46:549, 1973.
2. Abe M, Minagawa F, Yoshino Y, and Sasaki N: Application of of
iimunofluoresence to the studies on humoral and cellular 
antibodies in leprosy. Int. J. Lepr. 39:93-94, 1971.
3. Abe M, Minagawa F, Yoshino Y, Ozawa T, Savlawa K, and Saito T:
Fluorescent leprosy antibody absorption (FLA-ABS) test for 
detecting sub-clinical infections with Mycobacterium leprae.
Int. J. Lepr. 48:109-119, 1980.
4. Abrahams EW: Original mycobacterial sin. Tubercle 51:316-321,
1970.
5. Almserdier JO: Inhibition of Rubino factor as a test for detecting
antigens common to leprosy bacilli. Int. J. Lepr. 46:436, 1978.
6. Anthony J, Vaidya MC, and Dasgupta A: Ultrastructure of skin in
erythema nodosum leprosum. Cytobios. 36:17-23, 1983.
7. Aono G: A hemolytic reaction of erythrocyte sensitized with
tuberculin and component extracted from leprosy nodules. Tokyo 
J. Exp. Med. 57:311-316, 1953.
8 . Athwall RS, Deo SS, and Imaeda T: DNA relatedness among M.
lepramurium and selected bacteria by Dot Blot and 
spectrcphotcmetric DNA by hybridization. Int. J. of Sys. Bact. 
Oct:371-375, 1984.
9. Bach MA, Chatenoud L, Wallach D, Phan Dinh Tuy J, and Cottenot F:
Studies on T cell subsets and functions in leprosy. Clin. Exp. 
Immunol. 44:492-500, 1981.
10. Barker DJ: Epidemiology of Mycobacterium ulcerans infections.
Trans. R. Soc. Trop. Med. Hyg. 67:43-50, 1973.
11. Barksdale L: Leprosy vaccines. Int. J. Lepr. 51:102-109, 1983.
12. Barksdale L and Kim KS: Mycobacterium. Bactreriol.Rev.
41:217-372, 1977.
13. Barnhill RL and McDougall AC: Thalidomide: Use and possible mode
of action in reactional lepromatous leprosy and in various other 
conditions. J. Amer. Acad. Dermatol. Jt217-323, 1982.
14. Binford CH, Meyers WM, Walsh GP, Storrs EE, and Brown HL:
Naturally acquired leprosy-like disease in the nine-banded 
armadillo (Dasypus novemcinctus): Histopathologic and 
microbiologic studies of tissues. J. Ret. Soc. 22 : 377-388,
1977.
168
15. Binford CH, Meyers WM, and Walsh GP: Leprosy. JAMA 247:2283-2292,
1982.
16. Bjorvatn B, Bametson RS, Kronvall G, Zubler RH, and Lambert PH:
Iimune complexes and complement hypercatabolism in patients with 
leprosy. Clin. Exp; Lmnunol. 26:388-396, 1976.
17. Blomgren SE: Erythema nodosum. Semin. Arthritis Rheum. 4:1-24,
1980.
18. Boncmo L and Dammaoco F: Immune complex cryoglobulinemia in
lepromatous leprosy: A pathogenetic approach to some clinical
features of leprosy. Clin. Exp. Immunol. 9^ :175-181, 1971.
19. Brants J, Kamplemewthindung: Sreaktion mitdem tuberkulose - antigen
von witebsky, Kleingensteinuno Kuhn be. Lepra Dermatol. 
Wochenschr. 47:1688-1691, 1932.
20. Brennan PJ: The phthiocerol - containing surface lipids of
Mycobacterium leprae - a perspective of past and present work. 
Int. J. Lepr. (Editorial) 51:387-386.
21. Brennan PJ and Barrow WW: Evidence for species specific lipid
antiqens in Mycobacterium leprae. Int. J. Lepr. 48:382-387,
1980.
22. Brett SJ, Draper P, Payne SW, and Rees JW: Serological activity of
a characteristic phenolic glycolipid from M. leprae in sera from 
patients with leprosy and tuberculosis. Clin. Exp. Immunol. 
52:271-279, 1983.
23. Brubaker ML: Leprosy. In Tropical Medicine. Hunter, GW,
Swarzwelder JC, Clyde DF (eds), 5th Ed, WB Saunders Co, 212-223, 
1976.
24. Buchanan TM: Serodiagnosis of infection with Mycobacterium leprae.
Int. J. Lepr. 51:524-530, 1983.
25. Buchanan, Thomas: Personal communication.
26. Bullock WE: Anergy and infection. Adv. Int. ffed. 21:149-173,
1976.
27. Bullock WE: Leprosy: A model of inntunological perturbation in
chronic infection. J. Infect. Dis. 137:341-354, 1978.
28. Bullock WE: Studies of immune mechanisms in leprosy. I.
Depression of delayed allergic response to skin test antigens. 
N. Engl. J. Med. 278:298-304, 1968.
169
29. Bullock WE, Callerame ML, and Panner BJ: Immunohistologic
alteration of glomerular basement membranes in leprosy. Amer.
J. Trop Med. Hyg. 23;81-86, 1974.
30. Bullock WE, Ho MF, and Chen MJ: Studies of immune mechanisms in
leprosy. II. Quantitative relationships of IgG, IgA and IgM 
immunoglobulins. J. Lab. Clin. Med. 74:863-870, 1970.
31. Bullock WE, Watson S, Nelson KE, Schaui V, Makonkawkeyoon S, and
Jacobson RR: Aberrant iirerunoregulatory control of B lymphocyte
function in lepromatous leprosy. Clin. Exp. Immunol.
49:105-114, 1982.
32. Carpenter PL: Imranology and Serology. 3rd Ed, WB Saunders Co.,
New York, 1975, p. 280-281.
33. Cho SN, Yanagihara DL, Hunter SW, Gelber RH, and Brennan PJ:
Serological specificity of phenolic glycolipid-I fran 
Mycobacterium leprae and use in sero-diagnosis of leprosy.
Inf. Iimuin. 41:1077-1083, 1983.
34. Clarke HGM and Freeman T: Quantitative immunoelectrophoresis of
human serum proteins. Clin. Sci. 35:403-413, 1968.
35. Climatology Office, Louisiana State University, Baton Rouge
36. Clinical Biostatistics. Feinstein Alvan R CV Mosby Co, St Louis,
MO, pp. 468977.
37. Cochrane RG: Complicating conditions due to leprosy. In Leprosy
in Theory and Practice. Cochrane RG, Davy TF, (eds), 2nd Ed, 
The Williams & Wilkins Company, 1964, p. 331-343.
38. Convit J, Pinardi ME, and Arias Rojas F: Sane considerations
regarding the immunology of leprosy. Int. J. Lepr. 39:556-564,
1971.
39. Convit J, Pinardi ME, Rodriguez Ochoa G, Ulrfich M, Avila JL, and
Goihman M: Elimination of Mycobacterium leprae subsequent to
local in vivo activation of macrophages in lepromatous leprosy 
in other mycobacteria. Clin. Exp. Immunol. 17:261-265, 1974.
40. Cooke JW: Complement fixation with acid-fast leprosy bacteria. J.
Infect. Dis. 25:474-492, 1919.
41. Coombs RRA and Gell PGH: Classification of allergic reactions
responsible for clinical hypersensitivity and disease. In 
Clinical Aspects of Imnunology. Gell PGH, Coombs RRA, Lechmann 
BJ (eds), 3rd Ed, Blackwell Scientific Publications, Inc. 1975, 
pp. 761-781.
42. Cruishanti JB and Ellis BPB: Leprosy and the serodiagnostic test
for tuberculosis. J. Clin. Pathol. 30:728-730, 1977.
170
43. Cur ban GVA: A study of the Rubins reaction. Int. J. Lepr.
(Abstract) 32:352, 1964.
44. Douglas, James: Personal conmunication.
45. Drutz DJ, Cline MJ, and Levy L: Leukocyte antimicrobial function
in patients with leprosy. J. Clin. Invest. 53:380-386, 1974.
46. Eitner E: Veber dew nachweis von antikorpern im serum eines lepra
krandon mittels kanplorentablenkung. Weinie Klein Wochenschr 
19:1555-1557, 1906.
47. Fauci AS: Vasculitis. In Clinical Inmunology. Parker CW (Ed), WB
Saunders Co, 1980, pp. 473-519.
48. Fitch HS, Goodman P, and Coleman N: The armadillo in the
Southeastern United States. J. Mammology 33:21-37, 1952.
49. Gillis TP, Abe M, Bullock WE, Rojas-Espinosa D, Garcia-Ontigozae E,
Draper P, Kirchheimer W, and Buchanan IM: Comparison of 22
species of mycobacterium by immunodiffusion against an absorbed 
reference leprosy serum. Int. J. Lepr. 49:287-293, 1981.
50. Gillis TP, and Buchanan IM: Production and partial
characterization of monoclonal antibodies to Mycobacterium 
leprae. Infect. Immun. 37:172-178, 1982.
51. Godal T, LbFgren M, and Negaisir K: Immune response to M. leprae
of healthy contacts. Int. J. Lepr. 40:243-250, 1972.
52. Godal T, Myklestad B, Samuel DR, and Myrvang B: Characterization
of the cellular imrrune defect in lepromatous leprosy: A
specific lack of circulating Mycobacterium leprae-reactive 
lymphocytes. Clin. Exp. Immunol. 9:821-831, 1971.
53. Godal T, Myrvang B, Froland SS, Shao J, and Melaku G: Evidence
that the mechanism of iitnunological tolerance ('central 
failure') is operative in the lack cf host resistance in 
lepranatous leprosy. Scan. J. Brcnunol. 1:311-321, 1972.
54. Godal T, Myrvang B, Stanford JL and Samel, DR: Recent advances in
the imrrunology of leprosy with special references to new 
approaches in imnuno-prophylaxis. Bull. Pasteur. Int. 
72:273-310, 1974.
55. Godal T, Rees RJW, and Lamvik JO: Lymphocyte-mediated modification
of blood-derived macrophage function in vitro; inhibition of 
growth of intracellular mycobacteria with lymphokines. Clin. 
Exp. Immunol, j):625-637, 1971.
56. Goihman-Yahr M, Convit J, Rodriguez-Ochoa G, Aranzazu N,
Villalba-Pimentel L, Ocanto A, and de Gomez ME: Significance of
neutrophil activation in reactional lepromatous leprosy:
Effects of thalidomide in vivo and in vitro. Activation in
171
adjuvant disease. Int. Archs. Allergy Appl. Iirmun. 57:317-332,
1978.
57. Gupta RM, Gupta SC, Singh C and Rhanna S: Iirmunoglobulins in
leprosy. Int. J. Lepr. 46:342-345, 1978.
58. Jopling WH: Handbook of Leprosy. William Heinonann Medical Books,
Ltd., London, 1982, pp. 145.
59. Hansen, Armauer: Norsk Magabin Forlaegevden Ska ben. jl:76, 1874.
60. Harboe M: Radioiimunoassay and other serologic tests and their
application in epidemiological work. Lepr. Rev. 52:275-288,
1981.
61. Harboe M: Significance of antibody studies in leprosy and
experimental models of the disease. Int. J. Lepr. 50:342-350,
1982.
62. Harboe M, Closs 0, Bjune G, and Axelson NH: Mycobacterium leprae
specific antibodies detected by radio-imnunoassay. Scand. J. 
Immunol. 2*111-120, 1978.
63. Harboe M, Closs 0, Bjorvatn B, and Bjune G: Antibodies against BCG
antigen 60 in mycobacterial infection. Brit. Med. J. 2*430-433,
1977.
64. Harboe M, Closs 0, Bjune G, Kronvall G, and Axelson NH:
Mycobacterium leprae specific antibodies detected by 
radioinmunoassay. Scand. J. Imrtunol. 2 :1 H -120, 1978.
65. Harboe M, Closs 0, Bjorvatn B, Kronvall G, and Axelson NH:
Antibody response in rabbits to immunization with Mycobacterium 
leprae. Infect. & Immun. 18:792-805, 1977.
66. Harboe M, Closs 0, Rees RJW, and Walsh GP: Formation of antibody
against Mycobacterium leprae antigen in armadillos. J. Med. 
Microbiol. 11:525-535, 1978.
67. Harboe M, Closs 0, Reitan LJ and Draper P: Demonstration of
antibodies reacting with different antigens determinant on 
Mycobacterium leprae antigen 7. Int. J. Lepr. 49:147-148, 1981.
68. Hastings, Robert C: Personal ccmnunication.
69. Hastings RC, Morales MJ, and Shannon EJ: Studies on the mechanism
of action of thalidomide in leprosy. Pharmacologist 18:218,
1976.
70. Hastings RC: Clinical aspects of leprosy - Reactional episodes.
Proc. XI International Leprosy Congress, Mexico City, November 
13-18, 1978.
172
71. Hastings RC: Kellersberger Manorial Lecture 1979:
Iirmunosuppressive/anti-inflammatory thalidomide analogs.
Ethiop. Jfed. J. 18:65-71, 1980.
72. Herberman RB: Natural killer cells. Hosp. Prac. 17:937-103, 1982.
73. Higashi GX, El-Gothamy Z, and Habib MA: Inuunoglobulin deposits in
leprosy skin. Ann. Trcp. Med. Parasitol. 77:87-94, 1983.
74. Holborcw EJ and Reeves WS: Immunology in Medicine. Grune &
Stratton, Ed, New York, 1983. pp. 655.
75. Hurtphrey SR: Zoogeography of the nine banded armadillo (Dasypus
novemcinctus) in the United States. Bioscience 24:457-462.
76. Humphries RC, Gelber RH, and Krahenbuhl JL: Suppressed natural
killer cell activity during episodes of erythema nodosum 
leprosum in lepromatous leprosy. Clin. Exp. Immunol.
49:500-508, 1982.
77. Hunter SW and Brennan PJ: A novel phenolic glycolipid fran
Mycobacterium leprae possibly involved in iircnunogenicity and 
pathogenicity. J. Bacteriol. 147:728-735, 1982.
78. Hunter SW, Fujiwara T, and Brennan PJ: Structure and antigenicity
of the major specific qlycolipid antigen of Mycobacterium leprae. 
J. Biol. Chem. 257:15072-15078, 1982.
79. Immunoassays for the 80's. Voller A, Bartlett A, and Bidwell D,
Eds., Universal Park Press, Baltimore, 1980, pp. 508.
80. Irgens IM: Leprosy in Norway. Lepr. Rev. 51:1-133, 1980
(supplement).
81. Ivanyi JJ, Sinha S, Aston R, Cossell D, Reen M, and Sengupta V:
Definition of species specific and cross reactive antigens 
determinant of Mycobacterium leprae using monoclonal antigens. 
Clin. ESqp. Iirmunol. 52:528-536, June 1983.
82. Jacobson RR and Trautman JR: The diagnosis and treatment of
leprosy. Sou. Med. J. 69:979-985, 1976.
83. Jagonnath C and Sengupta DN: Serology of Leprosy. 1. Indirect
hsnogglutinatis test with stabilized sensitized red cells. Lepr. 
India 53:507-512, 1981.
84. Job CK: Leprosy - The source of infection and its mode of
transmission. Lepr. Rev. 52(Suppl 1): 69-76, 1981.
85. Job CK and Chacko CJG: A simplified 6 group classification of
leprosy. Lepr. India 54:26, 1982.
173
86. Job CK, Kirchheimer WF, and Sanchez KM: Liver lesions in
experimental lepromatoid leprosy of the armadillo: A
histopathologic study. Int. J. Lepr. 46:1-7, 1978.
87. Job CK, Gude S, and Macaden VP: Erythema nodosum leprosum: A
clinico-pathologic study. Int. J. Lepr. 32:177-184, 1964.
88. Jolliffe DS: Leprosy reactional states and their treatment. Brit.
J. Dermatol. 97:345-352, 1977.
89. Kano K, Aranzazu N, Nishimaki T, Convit J, Albini B, and Milgrcm F:
Serological and imnunohistological studies cn lepromatous 
leprosy. Int. Archs. Allergy Appl. Irranun. 64:19-24, 1981.
90. Kantor FS: Infection, anergy and cell-mediated immunity. N. Engl.
J. tfed. 292:629-634, 1975.
91. Kaplan MH and Chase Mtf: Antibodies to mycobacteria in human
tuberculosis. II. Response to nine defined antigens with 
evidence for antibodies common to tuberculosis and Mycobacterium 
leprae. J. Inf. Dis. 142:835, 1980.
92. Kazda J, Irgens IM, and Miller K: Isolation of non-cultivable
acid-fast bacilli in sphagnum moss and vegetation by foot pad 
technique in mice. Int. J. Lepr. 48:1-6, 1980.
93. Kirchheimer WF: The arnadillo as an experimental model in
biomedical research. Personal communication in: Pan American
Health Org. Pub., p.366, 1978.
94. Kirchheimer WF, Sanchez RM, and Shannon EJ: Effect of specific
vaccine on cell mediated inmunity of armadillos against M. 
leprae. Int., J. Lepr. 46:353-357, 1978.
95. Kirchheimer WF and Sanchez RM: Intraspecies differences of
resistance against leprosy in nine-banded armadillos. Lepr. 
India 53:525-530, 1981.
96. Kirchheimer WF and Sanchez RM: Leprosy-susceptibility testing of
armadillos. 1. Cellular responses to intradermally inoculated 
heat-killed leprosy bacilli. Microbios. 7^31-35, 1973.
97. Kirchheimer WF and Storrs EE: Attempts to establish the armadillo
(Dasypus novemcinctus, Linn.) as a model for the study of 
leprosy. 1. Report of lepromatoid leprosy in an experimentally 
infected armadillo. Int. J. Lepr. 39:693-702, 1971.
98. Kramarsky B, Edmondson HA, Peters RL, and Reynolds TB: Lepromatous
leprosy in reaction: A study of the liver and skin lesions.
Arch. Path. 85:516-531, 1968.
99. Kronvall G: The potential of immunological tests as tools in
epidemiology of leprosy. Lepr. Rev. 52:207-209, 1981.
174
100. Kronvall G, Stanford J, and Walsh GP: Studies of mycobacterial
antigens with special reference to Mycobacterium leprae. Inf. 
Immun. 13:1132-1138, 1976.
101. Kwapinski JBG, de Almeida JD, and Kwapinski, EH: Immunological
analysis of Mycobacterium leprae using cross reactions with 
cytoplasmic antigens of the Actioncnycutales. Can. J.
Microbiol. 18:391-306, 1975.
102. Kuper SWA: The lepromin reaction. In Leprosy in Theory and
Practice. Cochrane RG, Davy TF (eds), 2nd Ed, The Williams & 
Wilkins Company, 1964, p. 183-189.
103. Kwapinski JBG, de Almeida JD, and Kwapinski, EH: Immunological
analysis of Mycobacterium leprae using cross reactions with 
cytoplasmic antigens of the Actionarycutales. Can. J.
Microbiol. 18:391-306, 1975.
104. Lawley TJ, and Frank MM: Iitmune complexes and immune complex
diseases. In Clinical Immunology. Barker CW (ed), WB Saunders 
Co., 1980, p. 143-172.
105. Lever WF, and Schaumburg-Lever G: Histopathology of the Skin. 6th
Ed., JB Lippincott Co., 1983, p. 304-309.
106. Levine M, Chung-Hoon EK, Ichirin E, Arakak J, and Beaty M:
Serological response in various types and stages of Hansen's 
disease (leprosy) to tuberculin-sensitized sheep red blood cells. 
Int. J. Lepr. 20:201-202, 1952.
107. Levis, Robert: Personal communication.
108. Lincoln J: In Ecology and Field Biology. Smith RL, ed., Harper
and Row, New York, 1966, p. 636-661.
109. Londono F, Patarrcyo ME, de Rueda MMD, and Meneses A: Letter to
the editor. Arch. Dermatol. 113:234-235, 1977.
110. Lumpkin LR, Cox GS, and Wolf JE: Leprosy in five armadillo
handlers. J. Acad. Dermatol. 9^ :899-903, 1983.
111. Mammals of North America: ER Hall. John Wiley and Sons, Not York,
1981, pp. 1175.
112. Manual of Pharmacologic Calculations with Computer Programs:
Tallerda, R.J., Springer-Valley, New York, 1981, pp. 150.
113. Matthews LJ and Trautman JR: Clinical and serological profiles in
leprosy. Lancet 2,:915-917, 1965.
114. Matsuo E and Skinsnes OK: Inmunologic identification of M. leprae
by immunofluorescence and complement fixation. Int. J. Lepr. 
44:301-314, 1976.
175
115. JfcCornu.dk GTT and Sanchez R: Pyridine extractability of
acid-fastness from Mycobacterium leprae. Int. J. Lepr. 
47:495-499, 1979.
116. Mayers, Wayne: Personal ccranunication.
117. Meyers WM, Binford CH, Gerome PJ, and Wolf RH: Naturally acquired
leprosy in a mangabey monkey (Cercocebus sp.). Int. J. Lepr. 
48:495-496, 1980.
118. Middlebrook G: Immunology in leprosy. I. General aspects of the
immunology of mycobacterial infections. In Leprosy in Theory 
and Practice. Cochrane RG and Davy TF (eds), 2nd Ed, The 
Williams & Wilkins Company, 1964, p. 152-156.
119. Middlebrook G and Dubos RF: Specific serum agglutination of
erythrocytes sensitized with extract of tuberculin bacilli. J. 
Exp. Med. 88:521-528, 1984.
120. Miyachi Y, Ozaki M, and Niwa Y: Effects of thalidomide on the
generation of oxygen intermediates by zymosan-stimulated normal 
polymorphonuclear leukocytes. Arch. Dermatol. Res. 274:363-367, 
1982.
121. Jtodlin RL, Hofman FM, Meyer PR, Sharma OP, Taylor CR, and Rea TH:
In situ demonstration of T lymphocyte subsets in granulomatous 
inflammation: leprosy, rhinosclerama and sarcoidosis. Clin.
Exp. Immunol. 51:430-438, 1983.
122. Jtodlin RL, Hofman EM, Taylor CR, and Rea TH: In situ
characterization of T lymphocyte subsets in leprosy granulomas. 
Letter to the Editor. Int. J. Lepr. 50:361-362, 1982.
123. Moran CJ, Ryder G, Turk JL, and Waters MFR: Evidence for
circulating iimune complexes in lepromatous leprosy. Lancet 
2:572-573, 1972.
124. Mshana RN: Hypothesis: Erythema nodosum leprosum is precipitated
by an imbalance of T lymphocytes. Lepr. Rev. 53:1-7, 1982.
125. Mshana RN, Haregewoin A, Harboe M, and Belehu A: Thymus dependent
lymphocytes in leprosy. I. T lymphocyte subpopulations defined 
by monoclonal antibodies. Int. J. Lepr. 50:291-296, 1982.
126. Mshana RN, Humber DP, Belehu A, and Harboe M: Immunohistological
studies of skin biopsies from patients with lepromatous leprosy. 
J. Clin. Immunol. 3,;22-29, 1983.
127. Jtoorehouse PD and Hugh-Jones ME: Serum banks. Vet. Bull.
51:277-290, 1981.
176
128. Morris JA: Antibodies demonstrable during infection. In
Transactions of the Leonard Wood Manorial Symposium on Research 
in Leprosy. Leonard Wood Manorial, Baltimore, MD, pp. 79, 1961.
129. Mechanisms of reactions in leprosy. Editorial. Lancet 2^ :580-581,
1972.
130. Melsam R: Serodiagnosis of leprosy: The past, the present and seme
prospects for the future. Int. J. Lepr. 51:235-252, 1983.
131. Malscsn R, Harboe M, Doncan ME, and Bergsvik H: IgA and IgM against
Mycobacterium leprae in card sera and in patients with leprosy: 
An indicator of intrauterine infections in leprosy. Scand. J. 
Imnunol. 14:343-352, 1981.
132. Melsom R, Harboe M, and Duncan ME: IgA, IgM and IgG anti M. leprae
antibodies in babies of leprosy mothers during the first 2 years 
of life. Clin. Exp. Immunol. 49:532-542, 1982.
133. Melsom R, Harboe M, Myrvang B, Godal T, and Belehu A:
Immunoglobulin class specific antibody to M. leprae in leprosy 
patients, including the indeterminate group and healthy contacts 
as a step in the development of the method for sero-diagnosis of 
leprosy. Clin. Exp. Immunol. 47:225-233, 1982.
134. Melsom R, Harboe M, and Naafs B: Class specific anti-M. leprae
antibodies assay in lepromatous (BL-LL) leprosy patients during 
the first 2 to 4 years of DDS treatment. Int. J. Lepr. 
50:271-281, 1982.
135. Melsom R, Naafs B, Harboe M, and Closs O: Antibody activity
against Mycobacterium leprae antigens during the first year on 
DDS treatment in lepromatous (BL-LL) leprosy. Lepr. Rev. 
49:17-29, 1978.
136. Navalkar RG: Immunologic analysis of Mycobacterium leprae antigens
by means of gel diffusion methods. Int. J. Lepr. 39:105-111, 
1971.
137. Norlin M, Navalkar RG, Ouchterlony 0, and Lind A: Characterization
of leprosy sera with various nycobaterial antigens using double 
diffusion in gel. Acta. Path. Microbiol. Scand.
67:555-562, 1966.
138. Ouchterlony O: Antigen-antibody reactions in gels. Arkive. Kemio.
Minerals. Geol. ^6{B):l-9, 1948.
139. Poalett RC: The present status of the serodiagnosis of
tuberculosis. Bull. Int. Vtn. Tuber. 34:9-35, 1964.
140. Paul RC, Stanford JL, and Canswell JW: Multiple skin testing in 
leprosy. J. Hyg.(Camb) 75:57-68, 1975.
177
141. Payne SN, Draper P, and Rees RJW: Serological activity of purified
glycolipid fran Mycobacterium leprae (letter). Int. J. Lepr. 
50:220, 1982.
142. Pearson JMH: The use of corticosteroids in leprosy. Editorial.
Lep. Rev. 52:293-298, 1981.
143. Fortaels F and Pattyn SR: Taxonomy of Mycobacterium leprae and
Mycobacterium lepramurium. - Ann. Microbiol. (Inst. Pasteur), 
133B:99-1Q8, 1982.
144. Prabhakaran K, Harris EB, and Kirchheimer WF: Confirmation of the
spot test for identification of M. leprae and occurrence of 
tissue inhibition of Dopa oxidation. Lepr. Rev. 43:49-50, 1977.
145. Prabhakaran K and Kirchheimer WF: Use of 3,4-dihydroxphenylalanine
oxidation in the identification of M. leprae. J. Bacteriol. 
92:1267-68, 1966.
146. Quismorio FP, Rea TH, Chandor S, Levan N, and Friou GJ: Lucio's
phenomenon: An iirmne canplex deposition syndrome in
lepromatous leprosy. Clin. Immunol. Inmmcpath. j):184-193,
1978.
147. Quismorio FP, Rea TH, Levan NE, and Friou GJ: Immunoglobulin
deposits in lepromatous leprosy skin: Presence of deposits in
apparently uninvolved skin and occurrence of serum
antiepithelial antibodies. Arch. Dermatol. 111:331-334, 1975.
148. Rea TH, Levan NE, and Schweitzer RE: Erythema nodosum leprosum in
the absence of chemotherapy: A role for cell mediated immunity. 
Lancet Dec.9:1252, 1972.
149. Rea TH and Levan NE: Current concepts in the immunology of leprosy.
Arch. Dermatol. 113:345-352, 1977.
150. Rea TH and Levan NE: Erythana nodosum leprosum in a general
hospital. Arch. Dermatol. 111:1575-1580, 1975.
151. Rea TH, Quismorio FP, Harding B, Nies KM, Di Saia PJ, Levan NE, and
Friou GJ: Inmunologic responses in patients with lepromatous
leprosy. Arch. Dermatol. 112:791-800.
152. Rees RJW, Chat ter jee KR, Pepys J, and Tee RD: Sane immunological
aspects of leprosy. Am. J. Respir. Dis. S>2:139, 1965.
153. Ridley DS and Jopling WH: Classification of leprosy according to
inmunity: A five-group system. Int. J. Lepr. 34:225, 1966.
154. Ridley DS: Indeterminate leprosy. Lepr. Rev. 45:95-97, 1974.
155. Ridley DS, Rea TH, and McAdam KEWJ: The histology of erythema
nodosum leprosum: Variant forms in New Guineans and other
ethnic groups. Lepr. Rev. 52:65-78, 1981.
178
156. Ridley DS: Therapeutic trials in leprosy using serial biopsies.
Lepr. Rev. 29:45-52/ 1958.
157. Ridley MJ: The mononuclear cell series in leprosy: An
ultrastructural report. Lepr. Rev. 52:35-50, 1981.
158. Ridley MJ: Experimental granulomas induced by Mycobacterium leprae
imnune complexes in rats. Pathology 136:59-72, 1982.
159. Ridley MJ and Russell D: An intmuncperoxidase study of inmobilized
factors in high iraiune and low resistance granulomas in leprosy. 
J. Path. 137:149-157, 1982.
160. Rojas-Espinosa 0, Mendez-Navarrete I, and Estrada-Parra S:
Presence of Clq-reactive inraane complexes in patients with 
leprosy. Clin. Exp. Immunol. 12:215-223, 1972.
161. Rook GAW: Suppressor cells of mouse and man: What is the evidence
that they contribute to the aetiology of the nycobacterioses? 
Lepr. Rev. 53:306-312, 1982.
162. Rose H: The results of a modified Middlebrook-Dubois
hemagglutination test in leprosy: 261 cases. Int. J. Lepr. 
22:174-180, 1954.
163. Roth EE, Greer B, Moore M, Newman K, Sanford GE, and Adams WV:
Serologic analysis of two new related leptospiral serotypes 
isolated in Louisiana. Zoonoses Res. J3:3l-38* 1964.
164. Roth EE, et aL.: The epidemiology of Leptospirosis in Louisiana.
J. La. St. tfed. Soc. 4:110-115, 1965.
165. Roth EE: Leptospirosis in wildlife in the United States. AVMA.
Scientific Proc. JL:211-218, 1965.
166. Rubino MC: Sero-diagnositic des la lepre poer l'agglutenatino
sedimentation des globules de moulcn joumales. Ann. Inst. 
Pasteur (Paris) 47:144-172, 1931.
167. Sabin TD: Temperature-linked sensory loss. Arch. Neurol.
20:257-262, 1969.
168. Saha K, Chakrabarty AK, Sharma V, and Sehgal VN: An appraisal of
the third complement component (C3) and breakdown product (C3d) 
in erythema nodosum leprosum (ENL). Lepr. Rev. 53:253-260,
1982.
169. Saha K and Lahiri SC: Pharmacologically-active mediators of
hypersensitivity reactions in the blood of lepromatous patients 
with erythema nodosum leprosum. Lepr. Rev. 52:315-320, 1981.
179
170. Saha K and Mittal MM: Imrrunologic aspects of lepromatous leprosy
with special reference to the study of antibodies. Int. J.
Lepr. 40:260-264, 1972.
171. Saha K, Sharna V, Chakrabarty AK, and Sehgal VN: Breakdown product
of factor B as an index of complement activation in lepromatous 
leprosy and its relation with bacillary load. Scand. J.
Immunol. 17:37-43, 1983.
172. Sanchez, Rita: Personal ccnmunication.
173. Sansarrioq H: Recent changes in leprosy control. Lepr. Rev.
Special Issue l_t June 1983.
174. Sehgal S and Kurmar B: Circulating and tissue immune complexes in
leprosy. Int. J. Lepr. 49:294-300, 1981.
175. Shannon EJ, Truman KW, Vadiee R, Christy S, and Hastings R.C:
Effect of thalidomide on IgM antibody to the T-independent 
antigen DNP-Ficoll. Lepr. Rev. (in press), 1985.
176. Shannon EJ, Miranda RO, Morales MJ, and Hastings RC: Inhibition of
de novo IgM antibody synthesis by thalidomide as a relevant 
mechanism of action in leprosy. Scand. J. Immunol. 13:553-562,
1981.
177. Shannon EJ, Noah R, Christy S, and Hastings RC: Limitations of the
staph-A-radioimnunoassay in detecting antibodies to 
Mycobacterium leprae in armadillos. (In Preparation).
178. Shepard CC: The experimental disease that follows the injection of
human leprosy bacilli into foot-pads of mice. J. Exp. Med. 
112:445-454, 1960.
179. Shepard CC: Leprosy today. Editorial. N. Engl. J. Med.
307:1640-1641, 1982.
180. Shepard CC and McRae DH: A method for counting acid-fast bacteria.
Int. J. Lepr. 36:78-82, 1968.
181. Skinsnes OK: Immunology in leprosy. II. Immunological spectrum of
leprosy. In Leprosy in Theory and Practice. Cochrane RG, Davy 
TF (eds), 2nd Ed, The Williams & Wilkins Company, p.156-182, 
1964.
182. Skinsnes CK: Infectious granolomas. (Exposit from the leprosy
model). Ann. Rev. Med. 33:47-68, 1982.
183. Skinsnes CK: "Leprosy" in wild armadillos. Int. J. Lepr.
44:376-377, 1976.
184. Smith JH, Pile SK, Nagty BA, Folse DS, Buckner JA, Webb LJ, and
Beverding AM: Leprosy-like disease of wild armadillos in French
Acadiana, Louisiana. J. Ret. Soc. 24:705, 1978.
180
185. Smith JH, et al.: Leprosy in wild armadillos (Dasypus
novemcinctus) on the Gulf Coast: Epidemiology and
mycobacteriology. J. Ret. Soc. 14:75-88, 1983.
186. Soil Survey of Iberville Parish Louisiana. U.S. Dept.
Agriculture, Soil Conservation Service, 1971.
187. Soil Survey of Point Coupee and West Baton Rouge Parishes,
Louisiana. U.S. Dept. Agriculture, Soil conservation Service,
1982.
188. Soils and Coastal Marshes of Louisiana. La. Dept. Agr. Bull. 1143:
Center Wetlands Resources, Louisiana State University.
189. Stach JL, Strobel M, Fumoux P, and Bach JF: Defect in the
generation of cytotoxic T cells in lepromatous leprosy. Clin. 
Exp. Immunol. 48:633-640, 1982.
190. Stanford JL and Paul RC: A preliminary report on seme studies of
environmental mycobacteria. Ann. Soc. Belg. Trop. 53:389-393,
1973.
191. Stanford JL, Rook GfiW, Convit J, Godal T, Kronval G, Rees RJW,
and Walsh GP: Preliminary taxonomic studies on the leprosy
bacillus. Br. J. Exp. Pathol. 56:579-585, 1975.
192. Statistical Analysis Systems (SAS) Users Guide. SAS Institutes
Inc., SAS Users Guide Statistic, 1982 ed. Cary, NC, pp. 585,
1982.
193. Stoner GL: Hypothesis: Do phases of immunosuppression during a
Mycobacterium leprae infection determine the leprosy spectrum? 
Lepr. Rev. 52:1-10, 1981.
194. Starrs EE: The nine banded armadillo: A model for leprosy and
other biomedical research. Int. J. Lepr. 39:703-714, 1971.
195. Stuart BP, Crowell WA, Adams WV, and Carlisle TC: Spontaneous
renal disease in Louisiana armadillos. Wildlife Dis.
13:240-244, July 1977.
196. Taylor RN, et al.: Quality control for iirmunologic tests. HEW
Pub. No. (CDC) 79-8376, 1979.
197. Touw J, Langend JK, EMI, Stoner GL, and Belehu A: Humoral immunity
in leprosy: limunoglobulin G and M antibody responses to
Mycobacterium leprae in relation to various disease patterns. 
Infect. Lnnun. 316:885, 1982.
198. Truman RW, Shannon EJ, and Hastings RC: Development of an
enzyme-linked iimunosarbent assay for the detection of IgM class 
antibodies in armadillos to the phenolic glycolipid-1 antigen of 
M. leprae. Am. J. Trop. Med. (In press).
181
199. Tung, KSK, Kim B, Bjorvatn B, Kronvall G, McLaren LC, and Williams
EC: Discrepancy between Clq deviation and Raji cell tests in
detection o£ circulating iirmune complexes in patients with 
leprosy. J. Infect. Dis. 136:216-221, 1977.
200. Turk JL: Leprosy as a model of subacute and chronic immunologic
diseases. J. Invest. Dermatol. 67:457-463, 1976.
201. Turk JL and Bryceson ADM: Immunological phenomena in leprosy and
related diseases. Adv. Insnunol. 13:209-266, 1971.
202. Turk JL and Waters MFR: Cell-mediated immunity in patients with
leprosy. Lancet 2^ :243-246, 1969.
203. Ulrich M, Pinhardi ME, and Convit J: A study of antibody responses
in leprosy. Int. J. Lepr. 39:22-27, 1969.
204. Ulrich F and Zilversmit DB: Release from alveolar macrophages of
inhibitor of phagocytosis. Am. J. Physiol. 218:1118-1127, 1970.
205. Valentijn RM, Faber WR, Lai A Fat REM, Chan Pin Jie JC, Daha MR,
and van Es LA: Irrirune complexes in leprosy patients from an
endemic and a nonendemic area and a longitudinal study of the 
relationship between complement breakdown products and the 
clinical activity of erythema nodosum leprosum. Clin. Immunol. 
Immunopath. 22:194-202, 1982.
206. Van Voorhis WC, Kapan G, Sarno EN, Horwitz MA, Steinman RM, Levis
WR, Nogueira N, Hair IB, Gattass CR, Arrick BA, and Cohn ZA:
The cutaneous infiltrates of leprosy: Cellular characteristics
and the predominant T-cell phenotypes. N. Engl. J. Med. 
307:1593-1597, 1982.
207. Waksman BH: Cellular hypersensitivity and immunity: Inflamnation
and cytotoxicity. In Clinical Immunology. Barker CW (ed), WB 
Saunders Co, 1980.
208. Waldmann TA and Broder S: Polyclonal B-cell activators in the
study of the regulation of inwunoglobulin synthesis in the human 
systan. Adv. Immunol. JJ2:l-63, 1982.
209. Wallach D, Cottenot F, and Bach MA: Imbalances in T cell
subpopulations in lepromatous leprosy. Int. J. Lepr.
50:282-290, 1982.
210. Walsh GP, Storrs EE, Burchfield HP, Cottrell EH, Vidrine MF, and
Binford CH: Leprosy-like disease occurring naturally in 
armadillos. J. Ret. Soc. 18:347-351, 1975.
211. Walsh GP, Storrs ED, Meyers W, and Binford C: Naturally acquired
leprosy-like disease in the nine banded-armadillo (Dasypus 
novemcinctus): Recent epizootic findings. J. Ret. Soc. 22:363,
1977.
182
212. Vfaters MFR, Turk JL, and Wanambu SNC: Mechanisms of reactions in
leprosy. Int. J. Lepr. 39:417-428, 1971.
213. Wieigle WO: Cyclical production of antibody as a regulatory
mechanism in the immune response. Adv. Immunol. 21:87-111,
1975.
214. Vfemambu SNC, Turk JL, Waters MFR, and Rees RJW: Erythema nodosum
leprosum: A clinical manifestation of the Arthus phenomenon.
Lancet 2:933-935, 1980.
215. WHO Memorandum: "Recommended safety requirement for the
preparation of Lepranin." Bull. WHO 57:921-923, 1972.
216. Yoder IM, Naafs M, and Bjune G: Antibody activity against
Mycobacterium leprae antigen 7 in leprosy: Studies on variation
in antibody content throughout the leprosy spectrum and on the 
effect of DDS treatment and relapse in BT leprosy. Lepr. Rev. 
50:113-121, 1979.
217. Young DB: Human response predominately with IgM imnunoglobulin to
the species specific glycolipid of M. leprae. Int. J. Lepr.
149: 870-873, 1984.
183
Vita
Richard Truman was born 18 Feburary 1952 in South 
Charleston, West Virginia. Educated in public schools of 
Kentucky, North Caralina, Ohio and West Virginia, he 
completed his secondary education in 19 70 at Bluefield High 
School in Bluefield, West Virginia. He attended Bluefield 
State College in Bluefield, West Virginia, and received 
his Bachelorate degree in Biology at West Virginia 
University in 1974. He was employed as a Research 
Associate in the Veterinary Science Department at Louisiana 
State University and received a Masters degree in 
Microbiology in 19 78 from that institution. Following a 
period of employment and training in public health with 
the State of Louisiana Department of Health and Human 
Resources he returned to Louisiana State University and 
completed his Doctorate in Veterinary Microbiology and 
Parasitology in 1985. During his studies he was the 
recipient of the McKlesky Award from the South Central 
Branch of the American Society for Microbiology; and the 
J.D. Lane Award in the junior investigator category from 
the United States Public Health Service Professional 
Association.
DOCTORAL EXAMINATION AND DISSERTATION REPORT
Candidate: Richard W. Truman
Major Field: Veterinary Microbiology and Paras i to logy
Title o f  Dissertation: HOST RESPONSES TO THE P H E N O L IC -G L Y C O L IP ID -1  ANTIGEN OF 
MYCOBACTERIUM LEPRA E.
Approved:
M ajor Professor and Chairman 
Dean of the G raduate Scriool
EXAMINING COMMITTEE:
<^pWjA>\ <J I IxJ 1 W -L j
Jdy j/ __
^  ^ y / ^ 7  -_________
Date of Examination: April 1 / ,  1985
